{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T12:19:52Z","timestamp":1793621992181,"version":"4.5.0"},"reference-count":338,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["YCJJ20251101"],"award-info":[{"award-number":["YCJJ20251101"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research and Innovation Team Project for Scientific Breakthroughs at Shanxi Bethune Hospital","award":["2024AOXIANG04"],"award-info":[{"award-number":["2024AOXIANG04"]}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2023ZD0512300"],"award-info":[{"award-number":["2023ZD0512300"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82403471"],"award-info":[{"award-number":["82403471"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Hubei Province, China","award":["2024AFB058"],"award-info":[{"award-number":["2024AFB058"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"DOI":"10.1186\/s13045-025-01748-5","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:53:26Z","timestamp":1761656006000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["The neuro-immune axis in cancer: from mechanisms to therapeutic opportunities"],"prefix":"10.1186","volume":"18","author":[{"given":"Chunyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peikun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kongming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"1748_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021;221:107753.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"1748_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-024-00539-x","volume":"13","author":"Y Yin","year":"2024","unstructured":"Yin Y, Feng W, Chen J, Chen X, Wang G, Wang S, et al. Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside. Exp Hematol Oncol. 2024;13(1):72.","journal-title":"Exp Hematol Oncol"},{"issue":"3","key":"1748_CR3","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403.","journal-title":"Cancer Cell"},{"issue":"1","key":"1748_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-024-00543-1","volume":"13","author":"S Zheng","year":"2024","unstructured":"Zheng S, Wang W, Shen L, Yao Y, Xia W, Ni C. Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies. Exp Hematol Oncol. 2024;13(1):80.","journal-title":"Exp Hematol Oncol"},{"issue":"7","key":"1748_CR5","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41568-024-00705-7","volume":"24","author":"AM Holder","year":"2024","unstructured":"Holder AM, Dedeilia A, Sierra-Davidson K, Cohen S, Liu D, Parikh A, Boland GM. Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours. Nat Rev Cancer. 2024;24(7):498\u2013512.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1748_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-023-00372-8","volume":"12","author":"W Ma","year":"2023","unstructured":"Ma W, Xue R, Zhu Z, Farrukh H, Song W, Li T, et al. Increasing cure rates of solid tumors by immune checkpoint inhibitors. Exp Hematol Oncol. 2023;12(1):10.","journal-title":"Exp Hematol Oncol"},{"issue":"3","key":"1748_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ccell.2023.02.012","volume":"41","author":"D Hanahan","year":"2023","unstructured":"Hanahan D, Monje M. Cancer hallmarks intersect with neuroscience in the tumor microenvironment. Cancer Cell. 2023;41(3):573\u201380.","journal-title":"Cancer Cell"},{"issue":"10","key":"1748_CR8","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41573-024-01017-z","volume":"23","author":"D Yaniv","year":"2024","unstructured":"Yaniv D, Mattson B, Talbot S, Gleber-Netto FO, Amit M. Targeting the peripheral neural-tumour microenvironment for cancer therapy. Nat Rev Drug Discov. 2024;23(10):780\u201396.","journal-title":"Nat Rev Drug Discov"},{"key":"1748_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217492","volume":"612","author":"Y Huang","year":"2025","unstructured":"Huang Y, Zhou X, Liu J, Cao Y, Fu W, Yang J. Emerging neuroimmune mechanisms in cancer neuroscience. Cancer Lett. 2025;612:217492.","journal-title":"Cancer Lett"},{"issue":"1","key":"1748_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-024-00505-7","volume":"13","author":"J Lu","year":"2024","unstructured":"Lu J, Luo Y, Rao D, Wang T, Lei Z, Chen X, et al. Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion. Exp Hematol Oncol. 2024;13(1):39.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"1748_CR11","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12943-022-01657-y","volume":"21","author":"Y Wu","year":"2022","unstructured":"Wu Y, Yi M, Niu M, Mei Q, Wu K. Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy. Mol Cancer. 2022;21(1):184.","journal-title":"Mol Cancer"},{"issue":"1","key":"1748_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13045-023-01473-x","volume":"16","author":"X Cheng","year":"2023","unstructured":"Cheng X, Wang H, Wang Z, Zhu B, Long H. Tumor-associated myeloid cells in cancer immunotherapy. J Hematol Oncol. 2023;16(1):71.","journal-title":"J Hematol Oncol"},{"issue":"7965","key":"1748_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41586-023-05968-y","volume":"618","author":"R Mancusi","year":"2023","unstructured":"Mancusi R, Monje M. The neuroscience of cancer. Nature. 2023;618(7965):467\u201379.","journal-title":"Nature"},{"issue":"1","key":"1748_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0205-z","volume":"5","author":"RD Cervantes-Villagrana","year":"2020","unstructured":"Cervantes-Villagrana RD, Albores-Garc\u00eda D, Cervantes-Villagrana AR, Garc\u00eda-Acevez SJ. Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies. Signal Transduct Target Ther. 2020;5(1):99.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1748_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nrendo.2011.153","volume":"8","author":"AS Papadopoulos","year":"2012","unstructured":"Papadopoulos AS, Cleare AJ. Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome. Nat Rev Endocrinol. 2012;8(1):22\u201332.","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"1748_CR16","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/j.2040-4603.2019.tb00098.x","volume":"9","author":"E Carbone","year":"2019","unstructured":"Carbone E, Borges R, Eiden LE, Garc\u00eda AG, Hern\u00e1ndez-Cruz A. Chromaffin cells of the adrenal medulla: physiology, pharmacology, and disease. Compr Physiol. 2019;9(4):1443\u2013502.","journal-title":"Compr Physiol"},{"issue":"2","key":"1748_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/joa.13422","volume":"239","author":"CGJ Cleypool","year":"2021","unstructured":"Cleypool CGJ, Mackaaij C, Lotgerink Bruinenberg D, Schurink B, Bleys R. Sympathetic nerve distribution in human lymph nodes. J Anat. 2021;239(2):282\u20139.","journal-title":"J Anat"},{"issue":"1","key":"1748_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/jnr.490180107","volume":"18","author":"DL Felten","year":"1987","unstructured":"Felten DL, Ackerman KD, Wiegand SJ, Felten SY. Noradrenergic sympathetic innervation of the spleen: I. Nerve fibers associate with lymphocytes and macrophages in specific compartments of the splenic white pulp. J Neurosci Res. 1987;18(1):28\u201336.","journal-title":"J Neurosci Res"},{"issue":"1","key":"1748_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0165-5728(85)90031-1","volume":"10","author":"S Livnat","year":"1985","unstructured":"Livnat S, Felten SY, Carlson SL, Bellinger DL, Felten DL. Involvement of peripheral and central catecholamine systems in neural-immune interactions. J Neuroimmunol. 1985;10(1):5\u201330.","journal-title":"J Neuroimmunol"},{"issue":"12","key":"1748_CR20","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.tips.2004.10.007","volume":"25","author":"RH Straub","year":"2004","unstructured":"Straub RH. Complexity of the bi-directional neuroimmune junction in the spleen. Trends Pharmacol Sci. 2004;25(12):640\u20136.","journal-title":"Trends Pharmacol Sci"},{"key":"1748_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fimmu.2014.00023","volume":"5","author":"KM Kokolus","year":"2014","unstructured":"Kokolus KM, Spangler HM, Povinelli BJ, Farren MR, Lee KP, Repasky EA. Stressful presentations: mild cold stress in laboratory mice influences phenotype of dendritic cells in na\u00efve and tumor-bearing mice. Front Immunol. 2014;5:23.","journal-title":"Front Immunol"},{"issue":"50","key":"1748_CR22","doi-asserted-by":"publisher","first-page":"20176","DOI":"10.1073\/pnas.1304291110","volume":"110","author":"KM Kokolus","year":"2013","unstructured":"Kokolus KM, Capitano ML, Lee CT, Eng JW, Waight JD, Hylander BL, et al. Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature. Proc Natl Acad Sci U S A. 2013;110(50):20176\u201381.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1748_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cellimm.2011.04.003","volume":"270","author":"BL Mundy-Bosse","year":"2011","unstructured":"Mundy-Bosse BL, Thornton LM, Yang HC, Andersen BL, Carson WE. Psychological stress is associated with altered levels of myeloid-derived suppressor cells in breast cancer patients. Cell Immunol. 2011;270(1):80\u20137.","journal-title":"Cell Immunol"},{"key":"1748_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jneuroim.2017.12.016","volume":"315","author":"N Kuol","year":"2018","unstructured":"Kuol N, Stojanovska L, Apostolopoulos V, Nurgali K. Crosstalk between cancer and the neuro-immune system. J Neuroimmunol. 2018;315:15\u201323.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"1748_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1152\/physrev.00039.2016","volume":"98","author":"R Dantzer","year":"2018","unstructured":"Dantzer R. Neuroimmune interactions: from the brain to the immune system and vice versa. Physiol Rev. 2018;98(1):477\u2013504.","journal-title":"Physiol Rev"},{"issue":"2","key":"1748_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150230","volume":"11","author":"S St-Pierre","year":"2016","unstructured":"St-Pierre S, Jiang W, Roy P, Champigny C, LeBlanc \u00c9, Morley BJ, et al. Nicotinic acetylcholine receptors modulate bone marrow-derived pro-inflammatory monocyte production and survival. PLoS ONE. 2016;11(2):e0150230.","journal-title":"PLoS ONE"},{"issue":"12","key":"1748_CR27","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1172\/JCI129502","volume":"129","author":"H Mohammadpour","year":"2019","unstructured":"Mohammadpour H, MacDonald CR, Qiao G, Chen M, Dong B, Hylander BL, et al. B2 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells. J Clin Invest. 2019;129(12):5537\u201352.","journal-title":"J Clin Invest"},{"issue":"4","key":"1748_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109883","volume":"37","author":"H Mohammadpour","year":"2021","unstructured":"Mohammadpour H, MacDonald CR, McCarthy PL, Abrams SI, Repasky EA. \u03b22-adrenergic receptor signaling regulates metabolic pathways critical to myeloid-derived suppressor cell function within the TME. Cell Rep. 2021;37(4):109883.","journal-title":"Cell Rep"},{"issue":"5","key":"1748_CR29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41422-024-00946-z","volume":"34","author":"Q Xu","year":"2024","unstructured":"Xu Q, Cao Y, Kong F, Liu J, Chen X, Zhao Y, Lai CH, Zhou X, Hu H, Fu W, et al. Multiple cancer cell types release LIF and Gal3 to hijack neural signals. Cell Res. 2024;34(5):345\u201354.","journal-title":"Cell Res"},{"issue":"4","key":"1748_CR30","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1097\/SLA.0b013e318211d7b5","volume":"253","author":"Y Goldfarb","year":"2011","unstructured":"Goldfarb Y, Sorski L, Benish M, Levi B, Melamed R, Ben-Eliyahu S. Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses. Ann Surg. 2011;253(4):798\u2013810.","journal-title":"Ann Surg"},{"key":"1748_CR31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.bbi.2013.12.007","volume":"37","author":"E Rosenne","year":"2014","unstructured":"Rosenne E, Sorski L, Shaashua L, Neeman E, Matzner P, Levi B, Ben-Eliyahu S. In vivo suppression of NK cell cytotoxicity by stress and surgery: glucocorticoids have a minor role compared to catecholamines and prostaglandins. Brain Behav Immun. 2014;37:207\u201319.","journal-title":"Brain Behav Immun"},{"issue":"7","key":"1748_CR32","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41423-020-0477-9","volume":"17","author":"S Capellino","year":"2020","unstructured":"Capellino S, Claus M, Watzl C. Regulation of natural killer cell activity by glucocorticoids, serotonin, dopamine, and epinephrine. Cell Mol Immunol. 2020;17(7):705\u201311.","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"1748_CR33","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.4049\/jimmunol.170.10.5143","volume":"170","author":"JR Podojil","year":"2003","unstructured":"Podojil JR, Sanders VM. Selective regulation of mature IgG1 transcription by CD86 and beta 2-adrenergic receptor stimulation. J Immunol (Baltimore Md: 1950). 2003;170(10):5143\u201351.","journal-title":"J Immunol (Baltimore Md: 1950)"},{"issue":"4","key":"1748_CR34","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0031-6997(24)01510-2","volume":"53","author":"AP Kohm","year":"2001","unstructured":"Kohm AP, Sanders VM. Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4\u2009+\u2009t and b lymphocyte function in vitro and in vivo. Pharmacol Rev. 2001;53(4):487\u2013525.","journal-title":"Pharmacol Rev"},{"issue":"9","key":"1748_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045491","volume":"7","author":"L Wang","year":"2012","unstructured":"Wang L, Liu H, Chen X, Zhang M, Xie K, Ma Q. Immune sculpting of norepinephrine on MHC-I, B7-1, IDO and B7-H1 expression and regulation of proliferation and invasion in pancreatic carcinoma cells. PLoS ONE. 2012;7(9):e45491.","journal-title":"PLoS ONE"},{"issue":"41","key":"1748_CR36","doi-asserted-by":"publisher","first-page":"29919","DOI":"10.1074\/jbc.M611539200","volume":"282","author":"MB Nilsson","year":"2007","unstructured":"Nilsson MB, Armaiz-Pena G, Takahashi R, Lin YG, Trevino J, Li Y, Jennings N, Arevalo J, Lutgendorf SK, Gallick GE, et al. Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism. J Biol Chem. 2007;282(41):29919\u201326.","journal-title":"J Biol Chem"},{"issue":"46","key":"1748_CR37","doi-asserted-by":"publisher","first-page":"35462","DOI":"10.1074\/jbc.M110.109579","volume":"285","author":"MM Shahzad","year":"2010","unstructured":"Shahzad MM, Arevalo JM, Armaiz-Pena GN, Lu C, Stone RL, Moreno-Smith M, et al. Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis. J Biol Chem. 2010;285(46):35462\u201370.","journal-title":"J Biol Chem"},{"issue":"2","key":"1748_CR38","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1590\/1414-431X20133346","volume":"47","author":"R Yang","year":"2014","unstructured":"Yang R, Lin Q, Gao HB, Zhang P. Stress-related hormone norepinephrine induces interleukin-6 expression in GES-1 cells. Brazilian J Med Biol Res = Revista Brasileira De Pesquisas Medicas E Biologicas. 2014;47(2):101\u20139.","journal-title":"Brazilian J Med Biol Res = Revista Brasileira De Pesquisas Medicas E Biologicas"},{"issue":"6","key":"1748_CR39","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.18632\/oncotarget.2887","volume":"6","author":"GN Armaiz-Pena","year":"2015","unstructured":"Armaiz-Pena GN, Gonzalez-Villasana V, Nagaraja AS, Rodriguez-Aguayo C, Sadaoui NC, Stone RL, Matsuo K, Dalton HJ, Previs RA, Jennings NB, et al. Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growth. Oncotarget. 2015;6(6):4266\u201373.","journal-title":"Oncotarget"},{"issue":"11","key":"1748_CR40","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1158\/2326-6066.CIR-18-0833","volume":"7","author":"C Daher","year":"2019","unstructured":"Daher C, Vimeux L, Stoeva R, Peranzoni E, Bismuth G, Wieduwild E, et al. Blockade of \u03b2-Adrenergic receptors improves CD8(+) t-cell priming and cancer vaccine efficacy. Cancer Immunol Res. 2019;7(11):1849\u201363.","journal-title":"Cancer Immunol Res"},{"issue":"5","key":"1748_CR41","doi-asserted-by":"publisher","first-page":"295","DOI":"10.5483\/BMBRep.2015.48.5.008","volume":"48","author":"JF Qin","year":"2015","unstructured":"Qin JF, Jin FJ, Li N, Guan HT, Lan L, Ni H, Wang Y. Adrenergic receptor \u03b22 activation by stress promotes breast cancer progression through macrophages M2 polarization in tumor microenvironment. BMB Rep. 2015;48(5):295\u2013300.","journal-title":"BMB Rep"},{"key":"1748_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bbi.2019.06.004","volume":"81","author":"Y Xia","year":"2019","unstructured":"Xia Y, Wei Y, Li ZY, Cai XY, Zhang LL, Dong XR, et al. Catecholamines contribute to the neovascularization of lung cancer via tumor-associated macrophages. Brain Behav Immun. 2019;81:111\u201321.","journal-title":"Brain Behav Immun"},{"issue":"4","key":"1748_CR43","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/eji.201243005","volume":"43","author":"MG Guereschi","year":"2013","unstructured":"Guereschi MG, Araujo LP, Maricato JT, Takenaka MC, Nascimento VM, Vivanco BC, et al. Beta2-adrenergic receptor signaling in CD4\u2009+\u2009Foxp3\u2009+\u2009regulatory T cells enhances their suppressive function in a PKA-dependent manner. Eur J Immunol. 2013;43(4):1001\u201312.","journal-title":"Eur J Immunol"},{"issue":"1","key":"1748_CR44","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1158\/2326-6066.CIR-17-0401","volume":"6","author":"MD Nissen","year":"2018","unstructured":"Nissen MD, Sloan EK, Mattarollo SR. \u03b2-adrenergic signaling impairs antitumor CD8(+) T-cell responses to B-cell lymphoma immunotherapy. Cancer Immunol Res. 2018;6(1):98\u2013109.","journal-title":"Cancer Immunol Res"},{"issue":"18","key":"1748_CR45","doi-asserted-by":"publisher","first-page":"7042","DOI":"10.1158\/0008-5472.CAN-10-0522","volume":"70","author":"EK Sloan","year":"2010","unstructured":"Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010;70(18):7042\u201352.","journal-title":"Cancer Res"},{"issue":"6052","key":"1748_CR46","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1126\/science.1209985","volume":"334","author":"M Rosas-Ballina","year":"2011","unstructured":"Rosas-Ballina M, Olofsson PS, Ochani M, Vald\u00e9s-Ferrer SI, Levine YA, Reardon C, Tusche MW, Pavlov VA, Andersson U, Chavan S, et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science. 2011;334(6052):98\u2013101.","journal-title":"Science"},{"key":"1748_CR47","doi-asserted-by":"publisher","first-page":"10517","DOI":"10.1038\/ncomms10517","volume":"7","author":"Z Dubeykovskaya","year":"2016","unstructured":"Dubeykovskaya Z, Si Y, Chen X, Worthley DL, Renz BW, Urbanska AM, et al. Neural innervation stimulates splenic TFF2 to arrest myeloid cell expansion and cancer. Nat Commun. 2016;7:10517.","journal-title":"Nat Commun"},{"issue":"1","key":"1748_CR48","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13046-020-01796-4","volume":"39","author":"PL Pfitzinger","year":"2020","unstructured":"Pfitzinger PL, Fangmann L, Wang K, Demir E, G\u00fcrlevik E, Fleischmann-Mundt B, et al. Indirect cholinergic activation slows down pancreatic cancer growth and tumor-associated inflammation. J Exp Clin Cancer Res. 2020;39(1):289. https:\/\/doi.org\/10.1186\/s13046-020-01796-4.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"1748_CR49","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.bbadis.2007.11.005","volume":"1782","author":"E de la Torre","year":"2008","unstructured":"de la Torre E, Genaro AM, Ribeiro ML, Pagotto R, Pignataro OP, Sales ME. Proliferative actions of muscarinic receptors expressed in macrophages derived from normal and tumor bearing mice. Biochimica et Biophysica Acta (BBA). 2008;1782(2):82\u20139.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"11","key":"1748_CR50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2017762118","volume":"118","author":"W Zheng","year":"2021","unstructured":"Zheng W, Song H, Luo Z, Wu H, Chen L, Wang Y, et al. Acetylcholine ameliorates colitis by promoting IL-10 secretion of monocytic myeloid-derived suppressor cells through the nAChR\/ERK pathway. Proc Natl Acad Sci U S A. 2021;118(11):e2017762118.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21\u201322","key":"1748_CR51","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.lfs.2012.04.031","volume":"91","author":"T Fujii","year":"2012","unstructured":"Fujii T, Takada-Takatori Y, Kawashima K. Regulatory mechanisms of acetylcholine synthesis and release by T cells. Life Sci. 2012;91(21\u201322):981\u20135.","journal-title":"Life Sci"},{"issue":"32","key":"1748_CR52","doi-asserted-by":"publisher","first-page":"16541","DOI":"10.1074\/jbc.M115.710574","volume":"291","author":"SR Zanetti","year":"2016","unstructured":"Zanetti SR, Ziblat A, Torres NI, Zwirner NW, Bouzat C. Expression and functional role of \u03b17 nicotinic receptor in human cytokine-stimulated natural killer (NK) cells. J Biol Chem. 2016;291(32):16541\u201352.","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"1748_CR53","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jneuroim.2005.03.018","volume":"164","author":"JC Zimring","year":"2005","unstructured":"Zimring JC, Kapp LM, Yamada M, Wess J, Kapp JA. Regulation of CD8\u2009+\u2009cytolytic T lymphocyte differentiation by a cholinergic pathway. J Neuroimmunol. 2005;164(1\u20132):66\u201375.","journal-title":"J Neuroimmunol"},{"issue":"14","key":"1748_CR54","doi-asserted-by":"publisher","first-page":"22501","DOI":"10.18632\/oncotarget.15019","volume":"8","author":"LI Partecke","year":"2017","unstructured":"Partecke LI, K\u00e4ding A, Trung DN, Diedrich S, Sendler M, Weiss F, K\u00fchn JP, Mayerle J, Beyer K, von Bernstorff W, et al. Subdiaphragmatic vagotomy promotes tumor growth and reduces survival via TNF\u03b1 in a murine pancreatic cancer model. Oncotarget. 2017;8(14):22501\u201312.","journal-title":"Oncotarget"},{"issue":"11","key":"1748_CR55","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1158\/2159-8290.CD-18-0046","volume":"8","author":"BW Renz","year":"2018","unstructured":"Renz BW, Tanaka T, Sunagawa M, Takahashi R, Jiang Z, Macchini M, et al. Cholinergic signaling via muscarinic receptors directly and indirectly suppresses pancreatic tumorigenesis and cancer stemness. Cancer Discov. 2018;8(11):1458\u201373.","journal-title":"Cancer Discov"},{"issue":"7826","key":"1748_CR56","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41586-020-2425-3","volume":"585","author":"T Teratani","year":"2020","unstructured":"Teratani T, Mikami Y, Nakamoto N, Suzuki T, Harada Y, Okabayashi K, et al. The liver-brain-gut neural arc maintains the T(reg) cell niche in the gut. Nature. 2020;585(7826):591\u20136.","journal-title":"Nature"},{"issue":"7","key":"1748_CR57","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/jcp.2006.041475","volume":"60","author":"M Nowicki","year":"2007","unstructured":"Nowicki M, Ostalska-Nowicka D, Kondraciuk B, Miskowiak B. The significance of substance P in physiological and malignant haematopoiesis. J Clin Pathol. 2007;60(7):749\u201355.","journal-title":"J Clin Pathol"},{"issue":"1","key":"1748_CR58","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1189\/jlb.0408260","volume":"85","author":"I Chernova","year":"2009","unstructured":"Chernova I, Lai JP, Li H, Schwartz L, Tuluc F, Korchak HM, Douglas SD, Kilpatrick LE. Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R). J Leukoc Biol. 2009;85(1):154\u201364.","journal-title":"J Leukoc Biol"},{"issue":"22","key":"1748_CR59","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1007\/s00018-016-2293-z","volume":"73","author":"A Mashaghi","year":"2016","unstructured":"Mashaghi A, Marmalidou A, Tehrani M, Grace PM, Pothoulakis C, Dana R. Neuropeptide substance P and the immune response. Cell Mol Life Sci. 2016;73(22):4249\u201364.","journal-title":"Cell Mol Life Sci"},{"issue":"7935","key":"1748_CR60","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41586-022-05374-w","volume":"611","author":"M Balood","year":"2022","unstructured":"Balood M, Ahmadi M, Eichwald T, Ahmadi A, Majdoubi A, Roversi K, et al. Nociceptor neurons affect cancer immunosurveillance. Nature. 2022;611(7935):405\u201312.","journal-title":"Nature"},{"key":"1748_CR61","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.molimm.2017.08.020","volume":"91","author":"JX Duan","year":"2017","unstructured":"Duan JX, Zhou Y, Zhou AY, Guan XX, Liu T, Yang HH, et al. Calcitonin gene-related peptide exerts anti-inflammatory property through regulating murine macrophages polarization in vitro. Mol Immunol. 2017;91:105\u201313.","journal-title":"Mol Immunol"},{"issue":"4","key":"1748_CR62","doi-asserted-by":"publisher","first-page":"268","DOI":"10.2174\/13892037113149990046","volume":"14","author":"B Holzmann","year":"2013","unstructured":"Holzmann B. Antiinflammatory activities of CGRP modulating innate immune responses in health and disease. Curr Protein Pept Sci. 2013;14(4):268\u201374.","journal-title":"Curr Protein Pept Sci"},{"issue":"3","key":"1748_CR63","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1094-5539(03)00049-X","volume":"16","author":"J Springer","year":"2003","unstructured":"Springer J, Geppetti P, Fischer A, Groneberg DA. Calcitonin gene-related peptide as inflammatory mediator. Pulm Pharmacol Ther. 2003;16(3):121\u201330.","journal-title":"Pulm Pharmacol Ther"},{"issue":"4","key":"1748_CR64","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20209282","volume":"53","author":"G Zhao","year":"2020","unstructured":"Zhao G, Zhou W, Liu Y, Wang Y, Li Z, Song Z. Critical role of metabotropic glutamate receptor 4 in bone marrow-derived dendritic cells in the Th17 cell differentiation and the melanogenesis of B16 cells. Braz J Med Biol Res. 2020;53(4):e9282.","journal-title":"Braz J Med Biol Res"},{"key":"1748_CR65","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.intimp.2017.02.017","volume":"46","author":"G Zhao","year":"2017","unstructured":"Zhao G, Liu Y, Yi X, Wang Y, Qiao S, Li Z, Ni J, Song Z. Curcumin inhibiting Th17 cell differentiation by regulating the metabotropic glutamate receptor-4 expression on dendritic cells. Int Immunopharmacol. 2017;46:80\u20136.","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"1748_CR66","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1158\/2159-8290.CD-19-0154","volume":"9","author":"M Kansara","year":"2019","unstructured":"Kansara M, Thomson K, Pang P, Dutour A, Mirabello L, Acher F, et al. Infiltrating myeloid cells drive osteosarcoma progression via GRM4 regulation of IL23. Cancer Discov. 2019;9(11):1511\u20139.","journal-title":"Cancer Discov"},{"issue":"50","key":"1748_CR67","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj4226","volume":"7","author":"Z Wan","year":"2021","unstructured":"Wan Z, Sun R, Liu YW, Li S, Sun J, Li J, et al. Targeting metabotropic glutamate receptor 4 for cancer immunotherapy. Sci Adv. 2021;7(50):eabj4226.","journal-title":"Sci Adv"},{"issue":"1","key":"1748_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s40659-017-0110-2","volume":"50","author":"L Shanshiashvili","year":"2017","unstructured":"Shanshiashvili L, Tsitsilashvili E, Dabrundashvili N, Kalandadze I, Mikeladze D. Metabotropic glutamate receptor 5 may be involved in macrophage plasticity. Biol Res. 2017;50(1):4.","journal-title":"Biol Res"},{"key":"1748_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106565","volume":"84","author":"HB Abdalla","year":"2020","unstructured":"Abdalla HB, Napimoga MH, Lopes AH, de Macedo Maganin AG, Cunha TM, Van Dyke TE, et al. Activation of PPAR-\u03b3 induces macrophage polarization and reduces neutrophil migration mediated by heme oxygenase 1. Int Immunopharmacol. 2020;84:106565.","journal-title":"Int Immunopharmacol"},{"key":"1748_CR70","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ebiom.2019.10.063","volume":"50","author":"W Nowak","year":"2019","unstructured":"Nowak W, Grendas LN, Sanmarco LM, Estecho IG, Arena \u00c1R, Eberhardt N, et al. Pro-inflammatory monocyte profile in patients with major depressive disorder and suicide behaviour and how ketamine induces anti-inflammatory M2 macrophages by NMDAR and mTOR. EBioMedicine. 2019;50:290\u2013305.","journal-title":"EBioMedicine"},{"issue":"12","key":"1748_CR71","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1248\/bpb.b18-00055","volume":"41","author":"N Morikawa","year":"2018","unstructured":"Morikawa N, Tachibana M, Ago Y, Goda H, Sakurai F, Mizuguchi H. LY341495, an mGluR2\/3 antagonist, regulates the immunosuppressive function of Myeloid-Derived suppressor cells and inhibits melanoma tumor growth. Biol Pharm Bull. 2018;41(12):1866\u20139.","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"1748_CR72","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.bbrc.2015.04.015","volume":"461","author":"XL Cheng","year":"2015","unstructured":"Cheng XL, Ding F, Li H, Tan XQ, Liu X, Cao JM, Gao X. Activation of AMPA receptor promotes TNF-\u03b1 release via the ROS-cSrc-NF\u03baB signaling cascade in RAW264.7 macrophages. Biochem Biophys Res Commun. 2015;461(2):275\u201380.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"1748_CR73","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.4049\/jimmunol.170.8.4362","volume":"170","author":"Y Ganor","year":"2003","unstructured":"Ganor Y, Besser M, Ben-Zakay N, Unger T, Levite M. Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration. J Immunol (Baltimore Md: 1950). 2003;170(8):4362\u201372.","journal-title":"J Immunol (Baltimore Md: 1950)"},{"issue":"1","key":"1748_CR74","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.apsb.2019.12.006","volume":"10","author":"W Song","year":"2020","unstructured":"Song W, Li D, Tao L, Luo Q, Chen L. Solute carrier transporters: the metabolic gatekeepers of immune cells. Acta Pharm Sin B. 2020;10(1):61\u201378.","journal-title":"Acta Pharm Sin B"},{"issue":"5","key":"1748_CR75","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s00424-003-1117-9","volume":"447","author":"B Mackenzie","year":"2004","unstructured":"Mackenzie B, Erickson JD. Sodium-coupled neutral amino acid (System N\/A) transporters of the SLC38 gene family. Pflugers Arch Eur J Physiol. 2004;447(5):784\u201395.","journal-title":"Pflugers Arch Eur J Physiol"},{"issue":"6\u20137","key":"1748_CR76","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.neuint.2007.04.009","volume":"51","author":"AP Mashkina","year":"2007","unstructured":"Mashkina AP, Tyulina OV, Solovyova TI, Kovalenko EI, Kanevski LM, Johnson P, Boldyrev AA. The excitotoxic effect of NMDA on human lymphocyte immune function. Neurochem Int. 2007;51(6\u20137):356\u201360.","journal-title":"Neurochem Int"},{"issue":"611","key":"1748_CR77","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc8188","volume":"13","author":"MA Schneider","year":"2021","unstructured":"Schneider MA, Heeb L, Beffinger MM, Pantelyushin S, Linecker M, Roth L, et al. Attenuation of peripheral serotonin inhibits tumor growth and enhances immune checkpoint blockade therapy in murine tumor models. Sci Transl Med. 2021;13(611):eabc8188.","journal-title":"Sci Transl Med"},{"issue":"5","key":"1748_CR78","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1530\/EC-18-0145","volume":"7","author":"I Mendieta","year":"2018","unstructured":"Mendieta I, Nu\u00f1ez-Anita RE, P\u00e9rez-S\u00e1nchez G, Pav\u00f3n L, Rodr\u00edguez-Cruz A, Garc\u00eda-Alcocer G. Berumen LCJEc: Effect of A549 neuroendocrine differentiation on cytotoxic immune response. Endocr Connect. 2018;7(5):791\u2013802.","journal-title":"Endocr Connect."},{"issue":"4","key":"1748_CR79","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.molcel.2023.12.015","volume":"84","author":"X Wang","year":"2024","unstructured":"Wang X, Fu S-Q, Yuan X, Yu F, Ji Q, Tang H-W, Li R-K, Huang S, Huang P-Q. Qin W-TJMC: A GAPDH serotonylation system couples CD8\u2009+\u2009T cell glycolytic metabolism to antitumor immunity. Mol Cell. 2024;84(4):760\u201375.e767.","journal-title":"Mol Cell."},{"issue":"5","key":"1748_CR80","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.4049\/jimmunol.1201133","volume":"190","author":"M de las Casas-Engel","year":"2013","unstructured":"de las Casas-Engel M, Dom\u00ednguez-Soto A, Sierra-Filardi E, Bragado R, Nieto C, Puig-Kroger A, et al. Serotonin skews human macrophage polarization through HTR2B and HTR7. J Immunol. 2013;190(5):2301\u201310.","journal-title":"J Immunol"},{"issue":"10","key":"1748_CR81","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.4049\/jimmunol.1901531","volume":"204","author":"C Nieto","year":"2020","unstructured":"Nieto C, Rayo I, de Las Casas-Engel M, Izquierdo E, Alonso B, B\u00e9chade C, et al. Serotonin (5-HT) shapes the macrophage gene profile through the 5-HT(2B)-dependent activation of the aryl hydrocarbon receptor. J Immunol. 2020;204(10):2808\u201317.","journal-title":"J Immunol"},{"issue":"1","key":"1748_CR82","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/s41598-018-20173-y","volume":"8","author":"A Szabo","year":"2018","unstructured":"Szabo A, Gogolak P, Koncz G, Foldvari Z, Pazmandi K, Miltner N, Poliska S, Bacsi A, Djurovic S, Rajnavolgyi E. Immunomodulatory capacity of the serotonin receptor 5-HT2B in a subset of human dendritic cells. Sci Rep. 2018;8(1):1765.","journal-title":"Sci Rep"},{"issue":"15","key":"1748_CR83","first-page":"2866","volume":"128","author":"K Holst","year":"2015","unstructured":"Holst K, Guseva D, Schindler S, Sixt M, Braun A, Chopra H, Pabst O, Ponimaskin E. The serotonin receptor 5-HT\u2087R regulates the morphology and migratory properties of dendritic cells. J Cell Sci. 2015;128(15):2866\u201380.","journal-title":"J Cell Sci"},{"issue":"3","key":"1748_CR84","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1182\/blood-2005-07-2903","volume":"107","author":"PJ O\u2019Connell","year":"2006","unstructured":"O\u2019Connell PJ, Wang X, Leon-Ponte M, Griffiths C, Pingle SC, Ahern GP. A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells. Blood. 2006;107(3):1010\u20137.","journal-title":"Blood"},{"issue":"6","key":"1748_CR85","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1182\/blood-2012-06-437392","volume":"121","author":"D Duerschmied","year":"2013","unstructured":"Duerschmied D, Suidan GL, Demers M, Herr N, Carbo C, Brill A, Cifuni SM, Mauler M, Cicko S, Bader M, et al. Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice. Blood. 2013;121(6):1008\u201315.","journal-title":"Blood"},{"issue":"1","key":"1748_CR86","doi-asserted-by":"publisher","first-page":"10315","DOI":"10.1038\/s41598-017-10529-1","volume":"7","author":"Q Yang","year":"2017","unstructured":"Yang Q, Yan C, Gong Z. Activation of liver stromal cells is associated with male-biased liver tumor initiation in Xmrk and Myc transgenic zebrafish. Sci Rep. 2017;7(1):10315.","journal-title":"Sci Rep"},{"issue":"7","key":"1748_CR87","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S1567-5769(01)00068-6","volume":"1","author":"B Saha","year":"2001","unstructured":"Saha B, Mondal AC, Basu S, Dasgupta PS. Circulating dopamine level, in lung carcinoma patients, inhibits proliferation and cytotoxicity of CD4\u2009+\u2009and CD8\u2009+\u2009T cells by D1 dopamine receptors: an in vitro analysis. Int Immunopharmacol. 2001;1(7):1363\u201374.","journal-title":"Int Immunopharmacol"},{"key":"1748_CR88","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3389\/fphar.2019.01029","volume":"10","author":"Y Xia","year":"2019","unstructured":"Xia Y, Jia C, Xue Q, Jiang J, Xie Y, Wang R, Ran Z, Xu F, Zhang Y, Ye T. Antipsychotic drug trifluoperazine suppresses colorectal cancer by inducing G0\/G1 arrest and apoptosis. Front Pharmacol. 2019;10:1029.","journal-title":"Front Pharmacol"},{"issue":"8","key":"1748_CR89","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s00262-020-02816-0","volume":"70","author":"Q Liu","year":"2021","unstructured":"Liu Q, Zhang R, Zhang X, Liu J, Wu H, Li Y, et al. Dopamine improves chemotherapeutic efficacy for pancreatic cancer by regulating macrophage-derived inflammations. Cancer Immunol Immunother. 2021;70(8):2165-77. https:\/\/doi.org\/10.1007\/s00262-020-02816-0.","journal-title":"Cancer Immunol Immunother"},{"key":"1748_CR90","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ygyno.2023.06.019","volume":"176","author":"P Espa\u00f1ol","year":"2023","unstructured":"Espa\u00f1ol P, Rovira R, Caruana P, Luna-Guibourg R, Soler C, Teixeira N, Rodr\u00edguez F, Gallardo A, Edwards M, Porta O, et al. Dopamine receptors D1 and D2 show prognostic significance and potential therapeutic applications for endometrial cancer patients. Gynecol Oncol. 2023;176:25\u201335.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"1748_CR91","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2174\/1574892810666150416111831","volume":"10","author":"M Pornour","year":"2015","unstructured":"Pornour M, Ahangari G, Hejazi SH, Deezagi A. New perspective therapy of breast cancer based on selective dopamine receptor D2 agonist and antagonist effects on MCF-7 cell line. Recent Pat Anti-Cancer Drug Discov. 2015;10(2):214\u201323.","journal-title":"Recent Pat Anti-Cancer Drug Discov"},{"issue":"1","key":"1748_CR92","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1189\/jlb.5A1113-626RR","volume":"97","author":"J Wu","year":"2015","unstructured":"Wu J, Zhang R, Tang N, Gong Z, Zhou J, Chen Y, Chen K, Cai W. Dopamine inhibits the function of Gr-1\u2009+\u2009CD115\u2009+\u2009myeloid-derived suppressor cells through D1-like receptors and enhances anti-tumor immunity. J Leukoc Biol. 2015;97(1):191\u2013200.","journal-title":"J Leukoc Biol"},{"issue":"6","key":"1748_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065860","volume":"8","author":"W Zhao","year":"2013","unstructured":"Zhao W, Huang Y, Liu Z, Cao BB, Peng YP, Qiu YH. Dopamine receptors modulate cytotoxicity of natural killer cells via cAMP-PKA-CREB signaling pathway. PLoS ONE. 2013;8(6):e65860.","journal-title":"PLoS ONE"},{"issue":"1","key":"1748_CR94","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141(1):39\u201351.","journal-title":"Cell"},{"issue":"2","key":"1748_CR95","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41556-021-00820-9","volume":"24","author":"D Huang","year":"2022","unstructured":"Huang D, Wang Y, Thompson JW, Yin T, Alexander PB, Qin D, et al. Cancer-cell-derived GABA promotes \u03b2-catenin-mediated tumour growth and immunosuppression. Nat Cell Biol. 2022;24(2):230\u201341.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"1748_CR96","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/JLB.3HI0720-431R","volume":"110","author":"AK Bhandage","year":"2021","unstructured":"Bhandage AK, Friedrich LM, Kanatani S, Jakobsson-Bj\u00f6rk\u00e9n S, Escrig-Larena JI, Wagner AK, et al. GABAergic signaling in human and murine NK cells upon challenge with Toxoplasma gondii. J Leukoc Biol. 2021;110(4):617\u201328.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"1748_CR97","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1046\/j.1365-2249.2000.01354.x","volume":"122","author":"GT Verhoeven","year":"2000","unstructured":"Verhoeven GT, Van Haarst JM, De Wit HJ, Simons PJ, Hoogsteden HC, Drexhage HA. Glucocorticoids hamper the ex vivo maturation of lung dendritic cells from their low autofluorescent precursors in the human bronchoalveolar lavage: decreases in allostimulatory capacity and expression of CD80 and CD86. Clin Exp Immunol. 2000;122(2):232\u201340.","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"1748_CR98","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1182\/blood.V95.10.3162","volume":"95","author":"D Rea","year":"2000","unstructured":"Rea D, van Kooten C, van Meijgaarden KE, Ottenhoff TH, Melief CJ, Offringa R. Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10. Blood. 2000;95(10):3162\u20137.","journal-title":"Blood"},{"issue":"1","key":"1748_CR99","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00018-005-5390-y","volume":"63","author":"MJ Herold","year":"2006","unstructured":"Herold MJ, McPherson KG, Reichardt HM. Glucocorticoids in T cell apoptosis and function. Cell Mol Life Sci. 2006;63(1):60\u201372.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"1748_CR100","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nri.2017.1","volume":"17","author":"DW Cain","year":"2017","unstructured":"Cain DW, Cidlowski JA. Immune regulation by glucocorticoids. Nat Rev Immunol. 2017;17(4):233\u201347.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"1748_CR101","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2004-12-4790","volume":"106","author":"M L\u00f6wenberg","year":"2005","unstructured":"L\u00f6wenberg M, Tuynman J, Bilderbeek J, Gaber T, Buttgereit F, van Deventer S, et al. Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn. Blood. 2005;106(5):1703\u201310.","journal-title":"Blood"},{"issue":"4","key":"1748_CR102","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41577-020-00464-0","volume":"21","author":"MD Taves","year":"2021","unstructured":"Taves MD, Ashwell JD. Glucocorticoids in T cell development, differentiation and function. Nat Rev Immunol. 2021;21(4):233\u201343.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1748_CR103","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.immuni.2020.08.005","volume":"53","author":"N Acharya","year":"2020","unstructured":"Acharya N, Madi A, Zhang H, Klapholz M, Escobar G, Dulberg S, Christian E, Ferreira M, Dixon KO, Fell G, et al. Endogenous glucocorticoid signaling regulates CD8(+) T cell differentiation and development of dysfunction in the tumor microenvironment. Immunity. 2020;53(3):658\u2013e671656.","journal-title":"Immunity"},{"issue":"1","key":"1748_CR104","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.apsb.2021.06.002","volume":"12","author":"Y Wu","year":"2022","unstructured":"Wu Y, Luo X, Zhou Q, Gong H, Gao H, Liu T, et al. The disbalance of LRP1 and SIRP\u03b1 by psychological stress dampens the clearance of tumor cells by macrophages. Acta Pharm Sin B. 2022;12(1):197\u2013209.","journal-title":"Acta Pharm Sin B"},{"issue":"31","key":"1748_CR105","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1038\/s41388-021-01897-0","volume":"40","author":"Z Xiang","year":"2021","unstructured":"Xiang Z, Zhou Z, Song S, Li J, Ji J, Yan R, et al. Dexamethasone suppresses immune evasion by inducing GR\/STAT3 mediated downregulation of PD-L1 and IDO1 pathways. Oncogene. 2021;40(31):5002\u201312.","journal-title":"Oncogene"},{"issue":"1","key":"1748_CR106","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cellimm.2014.05.013","volume":"290","author":"JL Eddy","year":"2014","unstructured":"Eddy JL, Krukowski K, Janusek L, Mathews HL. Glucocorticoids regulate natural killer cell function epigenetically. Cell Immunol. 2014;290(1):120\u201330.","journal-title":"Cell Immunol"},{"issue":"8","key":"1748_CR107","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/sj.bjp.0707512","volume":"152","author":"DM Cavalcanti","year":"2007","unstructured":"Cavalcanti DM, Lotufo CM, Borelli P, Ferreira ZS, Markus RP, Farsky SH. Endogenous glucocorticoids control neutrophil mobilization from bone marrow to blood and tissues in non-inflammatory conditions. Br J Pharmacol. 2007;152(8):1291\u2013300.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"1748_CR108","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1161\/CIRCRESAHA.114.301374","volume":"114","author":"S Nadkarni","year":"2014","unstructured":"Nadkarni S, Dalli J, Hollywood J, Mason JC, Dasgupta B, Perretti M. Investigational analysis reveals a potential role for neutrophils in giant-cell arteritis disease progression. Circ Res. 2014;114(2):242\u20138.","journal-title":"Circ Res"},{"issue":"5","key":"1748_CR109","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S1097-2765(00)80323-8","volume":"5","author":"A Walther","year":"2000","unstructured":"Walther A, Riehemann K, Gerke V. A novel ligand of the formyl peptide receptor: Annexin I regulates neutrophil extravasation by interacting with the FPR. Mol Cell. 2000;5(5):831\u201340.","journal-title":"Mol Cell"},{"issue":"4","key":"1748_CR110","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2174\/138945011794751555","volume":"12","author":"AS Saffar","year":"2011","unstructured":"Saffar AS, Ashdown H, Gounni AS. The molecular mechanisms of glucocorticoids-mediated neutrophil survival. Curr Drug Targets. 2011;12(4):556\u201362.","journal-title":"Curr Drug Targets"},{"issue":"7915","key":"1748_CR111","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41586-022-04522-6","volume":"606","author":"X Guan","year":"2022","unstructured":"Guan X, Polesso F, Wang C, Sehrawat A, Hawkins RM, Murray SE, et al. Androgen receptor activity in T cells limits checkpoint blockade efficacy. Nature. 2022;606(7915):791\u20136.","journal-title":"Nature"},{"issue":"7","key":"1748_CR112","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.immuni.2022.05.012","volume":"55","author":"C Yang","year":"2022","unstructured":"Yang C, Jin J, Yang Y, Sun H, Wu L, Shen M, Hong X, Li W, Lu L, Cao D, et al. Androgen receptor-mediated CD8(+) T cell stemness programs drive sex differences in antitumor immunity. Immunity. 2022;55(7):1268\u2013e12831269.","journal-title":"Immunity"},{"issue":"73","key":"1748_CR113","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abq2630","volume":"7","author":"H Kwon","year":"2022","unstructured":"Kwon H, Schafer JM, Song N-J, Kaneko S, Li A, Xiao T, et al. Androgen conspires with the CD8\u2009+\u2009T cell exhaustion program and contributes to sex bias in cancer. Sci Immunol. 2022;7(73):eabq2630.","journal-title":"Sci Immunol"},{"issue":"19","key":"1748_CR114","first-page":"3958","volume":"29","author":"DP Anobile","year":"2023","unstructured":"Anobile DP, Salaroglio IC, Tabb\u00f2 F, La Vecchia S, Akman M, Napoli F, Bungaro M, Benso F, Aldieri E, Bironzo PJCCR. Autocrine 17-\u03b2-Estradiol\/Estrogen Receptor-\u03b1 loop determines the response to immune checkpoint inhibitors in Non\u2013Small. Cell Lung Cancer. 2023;29(19):3958\u201373.","journal-title":"Cell Lung Cancer"},{"issue":"11","key":"1748_CR115","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","volume":"21","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Allavena P, Marchesi F, Garlanda C. Macrophages as tools and targets in cancer therapy. Nat Rev Drug Discov. 2022;21(11):799\u2013820.","journal-title":"Nat Rev Drug Discov"},{"key":"1748_CR116","doi-asserted-by":"crossref","unstructured":"Chakraborty B, Byemerwa J, Shepherd J, Haines CN, Baldi R, Gong W, Liu W, Mukherjee D, Artham S. Lim fjtjoci: Inhibition of Estrogen signaling in myeloid cells increases tumor immunity in melanoma. J Clin Invest. 2021;131(23).","DOI":"10.1172\/JCI151347"},{"issue":"11","key":"1748_CR117","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1093\/carcin\/bgs260","volume":"33","author":"LP Stabile","year":"2012","unstructured":"Stabile LP, Rothstein ME, Cunningham DE, Land SR, Dacic S, Keohavong P, Siegfried JM. Prevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogens. Carcinogenesis. 2012;33(11):2181\u20139.","journal-title":"Carcinogenesis"},{"issue":"3","key":"1748_CR118","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jtho.2017.11.126","volume":"13","author":"LP Stabile","year":"2018","unstructured":"Stabile LP, Farooqui M, Kanterewicz B, Abberbock S, Kurland BF, Diergaarde B, et al. Preclinical evidence for combined use of aromatase inhibitors and NSAIDs as preventive agents of tobacco-induced lung cancer. J Thorac Oncol. 2018;13(3):399\u2013412.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"1748_CR119","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1158\/2159-8290.CD-16-0502","volume":"7","author":"N Svoronos","year":"2017","unstructured":"Svoronos N, Perales-Puchalt A, Allegrezza MJ, Rutkowski MR, Payne KK, Tesone AJ, et al. Tumor cell-independent estrogen signaling drives disease progression through mobilization of myeloid-derived suppressor cells. Cancer Discov. 2017;7(1):72\u201385.","journal-title":"Cancer Discov"},{"issue":"11","key":"1748_CR120","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/cac2.12605","volume":"44","author":"S Zeng","year":"2024","unstructured":"Zeng S, Hu H, Li Z, Hu Q, Shen R, Li M, et al. Local TSH\/TSHR signaling promotes CD8(+) T cell exhaustion and immune evasion in colorectal carcinoma. Cancer Commun. 2024;44(11):1287\u2013310.","journal-title":"Cancer Commun"},{"issue":"1","key":"1748_CR121","doi-asserted-by":"publisher","first-page":"e004049","DOI":"10.1136\/jitc-2021-004049","volume":"10","author":"Z Wu","year":"2022","unstructured":"Wu Z, Xi Z, Xiao Y, Zhao X, Li J, Feng N, et al. TSH-TSHR axis promotes tumor immune evasion. J Immunother Cancer. 2022;10(1):e004049. https:\/\/doi.org\/10.1136\/jitc-2021-004049","journal-title":"J Immunother Cancer"},{"issue":"1","key":"1748_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00745-7","volume":"6","author":"M Li","year":"2021","unstructured":"Li M, Hao B, Zhang M, Reiter RJ, Lin S, Zheng T, et al. Melatonin enhances radiofrequency-induced NK antitumor immunity, causing cancer metabolism reprogramming and inhibition of multiple pulmonary tumor development. Signal Transduct Target Ther. 2021;6(1):330.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"1748_CR123","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.apsb.2023.01.020","volume":"13","author":"YT Chan","year":"2023","unstructured":"Chan YT, Tan HY, Lu Y, Zhang C, Cheng CS, Wu J, et al. Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis. Acta Pharm Sin B. 2023;13(4):1554\u201367.","journal-title":"Acta Pharm Sin B"},{"key":"1748_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115649","author":"YC Chao","year":"2021","unstructured":"Chao YC, Lee KY, Wu SM, Kuo DY, Shueng PW, Lin CW. Melatonin downregulates PD-L1 expression and modulates tumor immunity in KRAS-mutant non-small cell lung cancer. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22115649.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1748_CR125","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1111\/cas.15338","volume":"113","author":"X Luo","year":"2022","unstructured":"Luo X, Chen Y, Tang H, Wang H, Jiang E, Shao Z, Liu K, Zhou X, Shang Z. Melatonin inhibits EMT and PD-L1 expression through the ERK1\/2\/FOSL1 pathway and regulates anti-tumor immunity in HNSCC. Cancer Sci. 2022;113(7):2232\u201345.","journal-title":"Cancer Sci"},{"issue":"1","key":"1748_CR126","doi-asserted-by":"publisher","first-page":"8451","DOI":"10.1038\/s41598-025-93486-4","volume":"15","author":"R Guo","year":"2025","unstructured":"Guo R, Rao PG, Liao BZ, Luo X, Yang WW, Lei XH, Ye JM. Melatonin suppresses PD-L1 expression and exerts antitumor activity in hepatocellular carcinoma. Sci Rep. 2025;15(1):8451.","journal-title":"Sci Rep"},{"key":"1748_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2023.111917","volume":"568\u2013569","author":"K Wang","year":"2023","unstructured":"Wang K, Cai R, Fei S, Chen X, Feng S, Zhang L, Liu H, Zhang Z, Song J, Zhou R. Melatonin enhances anti-tumor immunity by targeting macrophages PD-L1 via exosomes derived from gastric cancer cells. Mol Cell Endocrinol 2023;568\u2013569:111917. https:\/\/doi.org\/10.1016\/j.mce.2023.111917.","journal-title":"Mol Cell Endocrinol"},{"issue":"2 Suppl","key":"1748_CR128","doi-asserted-by":"publisher","first-page":"s755","DOI":"10.4049\/jimmunol.135.2.755","volume":"135","author":"DL Felten","year":"1985","unstructured":"Felten DL, Felten SY, Carlson SL, Olschowka JA, Livnat S. Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol (Baltimore Md: 1950). 1985;135(2 Suppl):s755-65.","journal-title":"J Immunol (Baltimore Md: 1950)"},{"issue":"1","key":"1748_CR129","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/jnr.490180108","volume":"18","author":"SY Felten","year":"1987","unstructured":"Felten SY, Olschowka J. Noradrenergic sympathetic innervation of the spleen: II. tyrosine hydroxylase (TH)-positive nerve terminals form synapticlike contacts on lymphocytes in the splenic white pulp. J Neurosci Res. 1987;18(1):37\u201348.","journal-title":"J Neurosci Res"},{"issue":"2","key":"1748_CR130","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1152\/physiolgenomics.00109.2004","volume":"19","author":"CK Ganta","year":"2004","unstructured":"Ganta CK, Blecha F, Ganta RR, Helwig BG, Parimi S, Lu N, et al. Hyperthermia-enhanced splenic cytokine gene expression is mediated by the sympathetic nervous system. Physiol Genomics. 2004;19(2):175\u201383.","journal-title":"Physiol Genomics"},{"issue":"4","key":"1748_CR131","doi-asserted-by":"publisher","first-page":"H1683","DOI":"10.1152\/ajpheart.00125.2005","volume":"289","author":"CK Ganta","year":"2005","unstructured":"Ganta CK, Lu N, Helwig BG, Blecha F, Ganta RR, Zheng L, et al. Central angiotensin II-enhanced splenic cytokine gene expression is mediated by the sympathetic nervous system. Am J Physiol Heart Circ Physiol. 2005;289(4):H1683-1691.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"1748_CR132","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1245\/s10434-008-9890-5","volume":"15","author":"M Benish","year":"2008","unstructured":"Benish M, Bartal I, Goldfarb Y, Levi B, Avraham R, Raz A, et al. Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol. 2008;15(7):2042\u201352.","journal-title":"Ann Surg Oncol"},{"key":"1748_CR133","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fphar.2015.00171","volume":"6","author":"A Scanzano","year":"2015","unstructured":"Scanzano A, Cosentino M. Adrenergic regulation of innate immunity: A review. Front Pharmacol. 2015;6:171.","journal-title":"Front Pharmacol."},{"issue":"8","key":"1748_CR134","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1002\/eji.201646395","volume":"46","author":"LD Estrada","year":"2016","unstructured":"Estrada LD, A\u011fa\u00e7 D, Farrar JD. Sympathetic neural signaling via the \u03b22-adrenergic receptor suppresses T-cell receptor-mediated human and mouse CD8\u2009+\u2009T-cell effector function. Eur J Immunol. 2016;46(8):1948\u201358.","journal-title":"Eur J Immunol"},{"key":"1748_CR135","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00164","volume":"9","author":"G Qiao","year":"2018","unstructured":"Qiao G, Chen M, Bucsek MJ, Repasky EA, Hylander BL. Adrenergic signaling: a targetable checkpoint limiting development of the antitumor immune response. Front Immunol. 2018;9:164.","journal-title":"Front Immunol"},{"issue":"9","key":"1748_CR136","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/s41591-019-0566-4","volume":"25","author":"H Yang","year":"2019","unstructured":"Yang H, Xia L, Chen J, Zhang S, Martin V, Li Q, Lin S, Chen J, Calmette J, Lu M, et al. Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity. Nat Med. 2019;25(9):1428\u201341.","journal-title":"Nat Med"},{"issue":"9","key":"1748_CR137","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41388-021-02170-0","volume":"41","author":"KY Fj\u00e6stad","year":"2022","unstructured":"Fj\u00e6stad KY, R\u00f8mer AMA, Goitea V, Johansen AZ, Thorseth ML, Carretta M, Engelholm LH, Gr\u00f8ntved L, Junker N, Madsen DH. Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment. Oncogene. 2022;41(9):1364\u201375.","journal-title":"Oncogene"},{"issue":"6","key":"1748_CR138","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1158\/2326-6066.CIR-20-0445","volume":"9","author":"G Qiao","year":"2021","unstructured":"Qiao G, Chen M, Mohammadpour H, MacDonald CR, Bucsek MJ, Hylander BL, Barbi JJ, Repasky EA. Chronic adrenergic stress contributes to metabolic dysfunction and an exhausted phenotype in T cells in the tumor microenvironment. Cancer Immunol Res. 2021;9(6):651\u201364.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"1748_CR139","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00262-018-2243-8","volume":"68","author":"G Qiao","year":"2019","unstructured":"Qiao G, Bucsek MJ, Winder NM, Chen M, Giridharan T, Olejniczak SH, et al. \u03b2-adrenergic signaling blocks murine CD8(+) T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress. Cancer Immunol Immunother. 2019;68(1):11\u201322.","journal-title":"Cancer Immunol Immunother"},{"issue":"8","key":"1748_CR140","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/cncr.28546","volume":"120","author":"L Jansen","year":"2014","unstructured":"Jansen L, Hoffmeister M, Arndt V, Chang-Claude J, Brenner H. Stage-specific associations between beta blocker use and prognosis after colorectal cancer. Cancer. 2014;120(8):1178\u201386.","journal-title":"Cancer"},{"key":"1748_CR141","doi-asserted-by":"publisher","first-page":"175135","DOI":"10.1016\/j.ejphar.2022.175135","volume":"929","author":"J Wang","year":"2022","unstructured":"Wang J, Lu S, Meng Y, Fu W, Zhou X. Beta adrenergic blockade and clinical outcomes in patients with colorectal cancer: a systematic review and meta-analysis. Eur J Pharmacol. 2022;929:175135. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175135.","journal-title":"Eur J Pharmacol"},{"key":"1748_CR142","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-036164","author":"R Ahl","year":"2020","unstructured":"Ahl R, Matthiessen P, Sj\u00f6lin G, Cao Y, Wallin G, Ljungqvist O, et al. Effects of beta-blocker therapy on mortality after elective colon cancer surgery: a Swedish nationwide cohort study. BMJ Open. 2020. https:\/\/doi.org\/10.1136\/bmjopen-2019-036164.","journal-title":"BMJ Open"},{"issue":"10","key":"1748_CR143","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1007\/s00268-019-05058-z","volume":"43","author":"R Ahl","year":"2019","unstructured":"Ahl R, Matthiessen P, Cao Y, Sjolin G, Ljungqvist O, Mohseni S. The relationship between severe complications, beta-blocker therapy and long-term survival following emergency surgery for colon cancer. World J Surg. 2019;43(10):2527\u201335.","journal-title":"World J Surg"},{"issue":"12","key":"1748_CR144","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.3390\/cancers11121856","volume":"11","author":"O Fiala","year":"2019","unstructured":"Fiala O, Ostasov P, Sorejs O, Liska V, Buchler T, Poprach A, et al. Incidental use of beta-blockers is associated with outcome of metastatic colorectal cancer patients treated with Bevacizumab-based therapy: a single-institution retrospective analysis of 514 patients. Cancers (Basel). 2019;11(12):1856. https:\/\/doi.org\/10.3390\/cancers11121856.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"1748_CR145","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.ejso.2018.05.012","volume":"44","author":"RP Musselman","year":"2018","unstructured":"Musselman RP, Bennett S, Li W, Mamdani M, Gomes T, van Walraven C, et al. Association between perioperative beta blocker use and cancer survival following surgical resection. Eur J Surg Oncol. 2018;44(8):1164\u20139.","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"1748_CR146","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1093\/annonc\/mdt381","volume":"24","author":"BM Hicks","year":"2013","unstructured":"Hicks BM, Murray LJ, Powe DG, Hughes CM, Cardwell CR. \u03b2-blocker usage and colorectal cancer mortality: a nested case-control study in the UK clinical practice research datalink cohort. Ann Oncol. 2013;24(12):3100\u20136.","journal-title":"Ann Oncol"},{"issue":"16","key":"1748_CR147","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1002\/cncr.26727","volume":"118","author":"L Jansen","year":"2012","unstructured":"Jansen L, Below J, Chang-Claude J, Brenner H, Hoffmeister M. Beta blocker use and colorectal cancer risk: population-based case-control study. Cancer. 2012;118(16):3911\u20139.","journal-title":"Cancer"},{"key":"1748_CR148","doi-asserted-by":"crossref","unstructured":"Fujii T, Mashimo M, Moriwaki Y, Misawa H, Ono S, Horiguchi K, Kawashima K. Expression and function of the cholinergic system in immune cells. Frontiers in Immunology 2017, 8(SEP).","DOI":"10.3389\/fimmu.2017.01085"},{"issue":"2","key":"1748_CR149","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031361","volume":"7","author":"G Gergalova","year":"2012","unstructured":"Gergalova G, Lykhmus O, Kalashnyk O, Koval L, Chernyshov V, Kryukova E, et al. Mitochondria express \u03b17 nicotinic acetylcholine receptors to regulate Ca2\u2009+\u2009accumulation and cytochrome c release: study on isolated mitochondria. PLoS ONE. 2012;7(2):e31361.","journal-title":"PLoS ONE"},{"issue":"1","key":"1748_CR150","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pharmthera.2012.08.012","volume":"137","author":"R Hurst","year":"2013","unstructured":"Hurst R, Rollema H, Bertrand D. Nicotinic acetylcholine receptors: from basic science to therapeutics. Pharmacol Ther. 2013;137(1):22\u201354.","journal-title":"Pharmacol Ther"},{"issue":"33","key":"1748_CR151","doi-asserted-by":"publisher","first-page":"20060","DOI":"10.1074\/jbc.M115.647040","volume":"290","author":"JR King","year":"2015","unstructured":"King JR, Nordman JC, Bridges SP, Lin MK, Kabbani N. Identification and characterization of a G protein-binding cluster in \u03b17 nicotinic acetylcholine receptors. J Biol Chem. 2015;290(33):20060\u201370.","journal-title":"J Biol Chem"},{"issue":"4","key":"1748_CR152","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.tips.2018.01.002","volume":"39","author":"N Kabbani","year":"2018","unstructured":"Kabbani N, Nichols RA. Beyond the channel: metabotropic signaling by nicotinic receptors. Trends Pharmacol Sci. 2018;39(4):354\u201366.","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"1748_CR153","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrc2590","volume":"9","author":"HM Schuller","year":"2009","unstructured":"Schuller HM. Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? Nat Rev Cancer. 2009;9(3):195\u2013205.","journal-title":"Nat Rev Cancer"},{"issue":"6440","key":"1748_CR154","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1126\/science.aaw5188","volume":"364","author":"S Maeda","year":"2019","unstructured":"Maeda S, Qu Q, Robertson MJ, Skiniotis G, Kobilka BK. Structures of the M1 and M2 muscarinic acetylcholine receptor\/G-protein complexes. Science. 2019;364(6440):552\u20137.","journal-title":"Science"},{"issue":"1\u20132","key":"1748_CR155","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jneuroim.2007.05.017","volume":"188","author":"YX Fujii","year":"2007","unstructured":"Fujii YX, Tashiro A, Arimoto K, Fujigaya H, Moriwaki Y, Misawa H, Fujii T, Matsui M, Kasahara T, Kawashima K. Diminished antigen-specific IgG1 and interleukin-6 production and acetylcholinesterase expression in combined M1 and M5 muscarinic acetylcholine receptor knockout mice. J Neuroimmunol. 2007;188(1\u20132):80\u20135.","journal-title":"J Neuroimmunol"},{"issue":"10","key":"1748_CR156","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/s43018-023-00624-w","volume":"4","author":"C Zheng","year":"2023","unstructured":"Zheng C, Snow BE, Elia AJ, Nechanitzky R, Dominguez-Brauer C, Liu S, Tong Y, Cox MA, Focaccia E, Wakeham AC, et al. Tumor-specific cholinergic CD4\u2009+\u2009T lymphocytes guide immunosurveillance of hepatocellular carcinoma. Nat Cancer. 2023;4(10):1437\u201354.","journal-title":"Nat Cancer"},{"issue":"4","key":"1748_CR157","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.neuron.2021.12.020","volume":"110","author":"SL Prescott","year":"2022","unstructured":"Prescott SL, Liberles SD. Internal senses of the vagus nerve. Neuron. 2022;110(4):579\u201399.","journal-title":"Neuron"},{"issue":"7795","key":"1748_CR158","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41586-020-1996-3","volume":"578","author":"M Amit","year":"2020","unstructured":"Amit M, Takahashi H, Dragomir MP, Lindemann A, Gleber-Netto FO, Pickering CR, Anfossi S, Osman AA, Cai Y, Wang R, et al. Loss of p53 drives neuron reprogramming in head and neck cancer. Nature. 2020;578(7795):449\u201354.","journal-title":"Nature"},{"key":"1748_CR159","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3389\/fimmu.2017.01463","volume":"8","author":"SL Foster","year":"2017","unstructured":"Foster SL, Seehus CR, Woolf CJ, Talbot S. Sense and immunity: context-dependent neuro-immune interplay. Front Immunol. 2017;8:1463.","journal-title":"Front Immunol"},{"issue":"7","key":"1748_CR160","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41577-019-0147-2","volume":"19","author":"P Baral","year":"2019","unstructured":"Baral P, Udit S, Chiu IM. Pain and immunity: implications for host defence. Nat Rev Immunol. 2019;19(7):433\u201347.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1748_CR161","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-8993(86)90716-X","volume":"365","author":"G Terenghi","year":"1986","unstructured":"Terenghi G, Polak JM, Rodrigo J, Mulderry PK, Bloom SR. Calcitonin gene-related peptide-immunoreactive nerves in the tongue, epiglottis and pharynx of the rat: occurrence, distribution and origin. Brain Res. 1986;365(1):1\u201314.","journal-title":"Brain Res"},{"issue":"4","key":"1748_CR162","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","volume":"94","author":"FA Russell","year":"2014","unstructured":"Russell FA, King R, Smillie SJ, Kodji X, Brain SD. Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev. 2014;94(4):1099\u2013142.","journal-title":"Physiol Rev"},{"issue":"9","key":"1748_CR163","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202200019","volume":"6","author":"LA McIlvried","year":"2022","unstructured":"McIlvried LA, Atherton MA, Horan NL, Goch TN, Scheff NN. Sensory neurotransmitter calcitonin gene-related peptide modulates tumor growth and lymphocyte infiltration in oral squamous cell carcinoma. Adv Biol. 2022;6(9):e2200019.","journal-title":"Adv Biol"},{"issue":"36","key":"1748_CR164","doi-asserted-by":"publisher","first-page":"13550","DOI":"10.1073\/pnas.0800767105","volume":"105","author":"M Toda","year":"2008","unstructured":"Toda M, Suzuki T, Hosono K, Hayashi I, Hashiba S, Onuma Y, et al. Neuronal system-dependent facilitation of tumor angiogenesis and tumor growth by calcitonin gene-related peptide. Proc Natl Acad Sci USA. 2008;105(36):13550\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"32","key":"1748_CR165","doi-asserted-by":"publisher","first-page":"12970","DOI":"10.1523\/JNEUROSCI.1974-13.2013","volume":"33","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Guan Z, Reader B, Shawler T, Mandrekar-Colucci S, Huang K, et al. Autonomic dysreflexia causes chronic immune suppression after spinal cord injury. J Neurosci. 2013;33(32):12970\u201381.","journal-title":"J Neurosci"},{"key":"1748_CR166","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fncel.2019.00033","volume":"13","author":"KR Jessen","year":"2019","unstructured":"Jessen KR, Mirsky R. The success and failure of the Schwann cell response to nerve injury. Front Cell Neurosci. 2019;13:33.","journal-title":"Front Cell Neurosci"},{"issue":"9","key":"1748_CR167","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202200089","volume":"6","author":"S Deborde","year":"2022","unstructured":"Deborde S, Wong RJ. The role of Schwann cells in cancer. Adv Biol. 2022;6(9):e2200089.","journal-title":"Adv Biol"},{"key":"1748_CR168","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00019","volume":"10","author":"T Huang","year":"2020","unstructured":"Huang T, Fan Q, Wang Y, Cui Y, Wang Z, Yang L, et al. Schwann cell-derived CCL2 promotes the perineural invasion of cervical cancer. Front Oncol. 2020;10:19.","journal-title":"Front Oncol"},{"issue":"10","key":"1748_CR169","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1158\/0008-5472.CAN-18-3872","volume":"79","author":"GV Shurin","year":"2019","unstructured":"Shurin GV, Kruglov O, Ding F, Lin Y, Hao X, Keskinov AA, et al. Melanoma-induced reprogramming of Schwann cell signaling aids tumor growth. Cancer Res. 2019;79(10):2736\u201347.","journal-title":"Cancer Res"},{"issue":"2","key":"1748_CR170","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4049\/jimmunol.1990024","volume":"204","author":"EM Oltz","year":"2020","unstructured":"Oltz EM. Neuroimmunology: to sense and protect. J Immunol (Baltimore Md: 1950). 2020;204(2):239\u201340.","journal-title":"J Immunol (Baltimore Md: 1950)"},{"issue":"11","key":"1748_CR171","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1007\/s00262-018-02296-3","volume":"68","author":"GV Martyn","year":"2019","unstructured":"Martyn GV, Shurin GV, Keskinov AA, Bunimovich YL, Shurin MR. Schwann cells shape the neuro-immune environs and control cancer progression. Cancer Immunol Immunother. 2019;68(11):1819\u201329.","journal-title":"Cancer Immunol Immunother"},{"issue":"8","key":"1748_CR172","doi-asserted-by":"publisher","first-page":"102863","DOI":"10.1016\/j.isci.2021.102863","volume":"24","author":"HJ Rosenberg","year":"2021","unstructured":"Rosenberg HJ, Rao M. Enteric glia in homeostasis and disease: from fundamental biology to human pathology. iScience. 2021;24(8):102863.","journal-title":"iScience"},{"issue":"5","key":"1748_CR173","volume":"1879","author":"K He","year":"2024","unstructured":"He K, Wang H, Huo R, Jiang SH, Xue J. Schwann cells and enteric glial cells: emerging stars in colorectal cancer. Biochimica et Biophysica Acta (BBA). 2024;1879(5):189160.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"8","key":"1748_CR174","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41575-021-00423-7","volume":"18","author":"L Seguella","year":"2021","unstructured":"Seguella L, Gulbransen BD. Enteric glial biology, intercellular signalling and roles in gastrointestinal disease. Nat Rev Gastroenterol Hepatol. 2021;18(8):571\u201387.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1748_CR175","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.595892","volume":"10","author":"R Yuan","year":"2020","unstructured":"Yuan R, Bhattacharya N, Kenkel JA, Shen J, DiMaio MA, Bagchi S, et al. Enteric glia play a critical role in promoting the development of colorectal cancer. Front Oncol. 2020;10:595892.","journal-title":"Front Oncol"},{"issue":"1","key":"1748_CR176","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jcmgh.2017.10.002","volume":"5","author":"E Duchalais","year":"2018","unstructured":"Duchalais E, Guilluy C, Nedellec S, Touvron M, Bessard A, Touchefeu Y, et al. Colorectal cancer cells adhere to and migrate along the neurons of the enteric nervous system. Cell Mol Gastroenterol Hepatol. 2018;5(1):31\u201349.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1748_CR177","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ebiom.2019.09.045","volume":"49","author":"S Val\u00e8s","year":"2019","unstructured":"Val\u00e8s S, Bacola G, Biraud M, Touvron M, Bessard A, Geraldo F, et al. Tumor cells hijack enteric glia to activate colon cancer stem cells and stimulate tumorigenesis. EBioMedicine. 2019;49:172\u201388.","journal-title":"EBioMedicine"},{"issue":"28","key":"1748_CR178","first-page":"2165","volume":"7","author":"CR Hansebout","year":"2012","unstructured":"Hansebout CR, Su C, Reddy K, Zhang D, Jiang C, Rathbone MP, et al. Enteric glia mediate neuronal outgrowth through release of neurotrophic factors. Neural Regen Res. 2012;7(28):2165\u201375.","journal-title":"Neural Regen Res"},{"issue":"2","key":"1748_CR179","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/jnci\/djp456","volume":"102","author":"Z Gil","year":"2010","unstructured":"Gil Z, Cavel O, Kelly K, Brader P, Rein A, Gao SP, Carlson DL, Shah JP, Fong Y, Wong RJ. Paracrine regulation of pancreatic cancer cell invasion by peripheral nerves. J Natl Cancer Inst. 2010;102(2):107\u201318.","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"1748_CR180","doi-asserted-by":"publisher","first-page":"E2008","DOI":"10.1073\/pnas.1402944111","volume":"111","author":"S He","year":"2014","unstructured":"He S, Chen CH, Chernichenko N, He S, Bakst RL, Barajas F, et al. GFR\u03b11 released by nerves enhances cancer cell perineural invasion through GDNF-RET signaling. Proc Natl Acad Sci U S A. 2014;111(19):E2008-2017.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"1748_CR181","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009159","volume":"16","author":"Z Dong","year":"2020","unstructured":"Dong Z, Dai L, Zhang Y, Fang C, Shi G, Chen Y, et al. Hypomethylation of GDNF family receptor alpha 1 promotes epithelial-mesenchymal transition and predicts metastasis of colorectal cancer. PLoS Genet. 2020;16(11):e1009159.","journal-title":"PLoS Genet"},{"issue":"1","key":"1748_CR182","doi-asserted-by":"publisher","first-page":"6079","DOI":"10.1038\/s41467-024-50438-2","volume":"15","author":"L van Baarle","year":"2024","unstructured":"van Baarle L, De Simone V, Schneider L, Santhosh S, Abdurahiman S, Biscu F, Schneider R, Zanoletti L, de Siqueira R, Verbandt S, et al. IL-1R signaling drives enteric glia-macrophage interactions in colorectal cancer. Nat Commun. 2024;15(1):6079.","journal-title":"Nat Commun"},{"issue":"4","key":"1748_CR183","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1073\/pnas.1112495109","volume":"109","author":"A Cassago","year":"2012","unstructured":"Cassago A, Ferreira AP, Ferreira IM, Fornezari C, Gomes ER, Greene KS, Pereira HM, Garratt RC, Dias SM, Ambrosio AL. Mitochondrial localization and structure-based phosphate activation mechanism of glutaminase C with implications for cancer metabolism. Proc Natl Acad Sci U S A. 2012;109(4):1092\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1748_CR184","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","volume":"7","author":"RJ DeBerardinis","year":"2008","unstructured":"DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7(1):11\u201320.","journal-title":"Cell Metab"},{"issue":"2\u20133","key":"1748_CR185","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10295-015-1665-y","volume":"43","author":"MC Walker","year":"2016","unstructured":"Walker MC, van der Donk WA. The many roles of glutamate in metabolism. J Ind Microbiol Biotechnol. 2016;43(2\u20133):419\u201330.","journal-title":"J Ind Microbiol Biotechnol"},{"issue":"6","key":"1748_CR186","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0092-8674(00)80584-X","volume":"96","author":"F Aslund","year":"1999","unstructured":"Aslund F, Beckwith J. Bridge over troubled waters: sensing stress by disulfide bond formation. Cell. 1999;96(6):751\u20133.","journal-title":"Cell"},{"issue":"8","key":"1748_CR187","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00702-014-1182-6","volume":"121","author":"A Stepulak","year":"2014","unstructured":"Stepulak A, Rola R, Polberg K, Ikonomidou C. Glutamate and its receptors in cancer. J Neural Transmission (Vienna Austria: 1996). 2014;121(8):933\u201344.","journal-title":"J Neural Transmission (Vienna Austria: 1996)"},{"issue":"7","key":"1748_CR188","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00702-016-1661-z","volume":"124","author":"M Levite","year":"2017","unstructured":"Levite M. Glutamate, T cells and multiple sclerosis. J Neural Transm. 2017;124(7):775\u201398.","journal-title":"J Neural Transm"},{"key":"1748_CR189","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102007","volume":"41","author":"C MGGDCMFMRMC","year":"2020","unstructured":"C MGGDCMFMRMC. Platelet glutamate uptake and Th1 cells inversely correlate in relapsing\/remitting and in progressive multiple sclerosis. Mult Scler Relat Disord. 2020;41:102007.","journal-title":"Mult Scler Relat Disord"},{"key":"1748_CR190","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","volume":"50","author":"CM Niswender","year":"2010","unstructured":"Niswender CM, Conn PJ. Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol. 2010;50:295\u2013322.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"1748_CR191","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/cmi.2012.10","volume":"9","author":"G Huang","year":"2012","unstructured":"Huang G, Wang Y, Chi H. Regulation of TH17 cell differentiation by innate immune signals. Cell Mol Immunol. 2012;9(4):287\u201395.","journal-title":"Cell Mol Immunol"},{"issue":"7","key":"1748_CR192","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1128\/IAI.00200-08","volume":"76","author":"SR Paccani","year":"2008","unstructured":"Paccani SR, Dal Molin F, Benagiano M, Ladant D, D\u2019Elios MM, Montecucco C, et al. Suppression of T-lymphocyte activation and chemotaxis by the adenylate cyclase toxin of Bordetella pertussis. Infect Immun. 2008;76(7):2822\u201332.","journal-title":"Infect Immun"},{"issue":"7","key":"1748_CR193","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1016\/j.ymthe.2021.03.013","volume":"29","author":"N Liu","year":"2021","unstructured":"Liu N, Zhang J, Yin M, Liu H, Zhang X, Li J, et al. Inhibition of xCT suppresses the efficacy of anti-PD-1\/L1 melanoma treatment through exosomal PD-L1-induced macrophage M2 polarization. Mol Ther. 2021;29(7):2321\u201334.","journal-title":"Mol Ther"},{"key":"1748_CR194","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.216021","volume":"554","author":"B Tang","year":"2023","unstructured":"Tang B, Wang Y, Xu W, Zhu J, Weng Q, Chen W, et al. Macrophage xCT deficiency drives immune activation and boosts responses to immune checkpoint blockade in lung cancer. Cancer Lett. 2023;554:216021.","journal-title":"Cancer Lett"},{"issue":"2","key":"1748_CR195","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1096\/fj.04-2079rev","volume":"19","author":"A Slominski","year":"2005","unstructured":"Slominski A, Wortsman J, Tobin DJJTFJ. The cutaneous serotoninergic\/melatoninergic system: securing a place under the sun. FASEB J. 2005;19(2):176\u201394.","journal-title":"FASEB J"},{"key":"1748_CR196","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.phrs.2018.08.005","volume":"140","author":"G Fouquet","year":"2019","unstructured":"Fouquet G, Coman T, Hermine O. C\u00f4t\u00e9 fjpr: Serotonin, hematopoiesis and stem cells.Pharmacol Res. 2019;140:67\u201374.","journal-title":"Pharmacol Res."},{"issue":"4","key":"1748_CR197","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1210\/er.2018-00283","volume":"40","author":"JM Yabut","year":"2019","unstructured":"Yabut JM, Crane JD, Green AE, Keating DJ, Khan WI. Steinberg grjer: emerging roles for serotonin in regulating metabolism: new implications for an ancient molecule. Endocr Rev. 2019;40(4):1092\u2013107.","journal-title":"Endocr Rev."},{"key":"1748_CR198","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107423","volume":"205","author":"MJP Bader","year":"2020","unstructured":"Bader MJP. Therapeutics: Inhibition of serotonin synthesis: A novel therapeutic paradigm. Pharmacol Ther. 2020;205:107423.","journal-title":"Pharmacol Ther."},{"issue":"10","key":"1748_CR199","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102418","volume":"10","author":"F Reverchon","year":"2022","unstructured":"Reverchon F, Guillard C, Mollet L, Auzou P, Gosset D, Madouri F, et al. T lymphocyte serotonin 5-HT7 receptor is dysregulated in Natalizumab-treated multiple sclerosis patients. Biomedicines. 2022;10(10):2418.","journal-title":"Biomedicines"},{"key":"1748_CR200","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.04.032","author":"B Li","year":"2025","unstructured":"Li B, Elsten-Brown J, Li M, Zhu E, Li Z, Chen Y, et al. Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis. Cell. 2025. https:\/\/doi.org\/10.1016\/j.cell.2025.04.032.","journal-title":"Cell"},{"issue":"11","key":"1748_CR201","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020;20(11):651\u201368.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1748_CR202","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26612-0","volume":"8","author":"Q Yang","year":"2018","unstructured":"Yang Q, Yan C, Gong ZJSR. Interaction of hepatic stellate cells with neutrophils and macrophages in the liver following oncogenic Kras activation in transgenic zebrafish. Sci Rep. 2018;8(1):8495.","journal-title":"Sci Rep"},{"issue":"1","key":"1748_CR203","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10529-1","volume":"7","author":"Q Yang","year":"2017","unstructured":"Yang Q, Yan C, Gong ZJSR. Activation of liver stromal cells is associated with male-biased liver tumor initiation in Xmrk and Myc transgenic zebrafish. Sci Rep. 2017;7(1):10315.","journal-title":"Sci Rep"},{"issue":"33","key":"1748_CR204","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202002739","volume":"32","author":"L Tang","year":"2020","unstructured":"Tang L, Wang Z, Mu Q, Yu Z, Jacobson O, Li L, et al. Targeting neutrophils for enhanced cancer theranostics. Adv Mater. 2020;32(33):2002739.","journal-title":"Adv Mater"},{"issue":"43","key":"1748_CR205","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202205787","volume":"32","author":"K Yao","year":"2022","unstructured":"Yao K, Mu Q, Zhang Y, Cheng Q, Cheng X, Liu X, et al. Hesperetin nanoparticle targeting neutrophils for enhanced TBI therapy. Adv Funct Mater. 2022;32(43):2205787.","journal-title":"Adv Funct Mater"},{"issue":"1","key":"1748_CR206","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15348-y","volume":"7","author":"\u00c1 Dom\u00ednguez-Soto","year":"2017","unstructured":"Dom\u00ednguez-Soto \u00c1, Usategui A, Casas-Engel ML, Sim\u00f3n-Fuentes M, Nieto C, Cuevas VD, et al. Serotonin drives the acquisition of a profibrotic and anti-inflammatory gene profile through the 5-HT7R-PKA signaling axis. Sci Rep. 2017;7(1):14761.","journal-title":"Sci Rep"},{"issue":"10","key":"1748_CR207","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.4049\/jimmunol.172.10.6011","volume":"172","author":"M Idzko","year":"2004","unstructured":"Idzko M, Panther E, Stratz C, M\u00fcller T, Bayer H, Zissel G, et al. The serotoninergic receptors of human dendritic cells: identification and coupling to cytokine release. J Immunol. 2004;172(10):6011\u20139.","journal-title":"J Immunol"},{"issue":"8","key":"1748_CR208","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1182\/blood-2006-10-052787","volume":"109","author":"M Le\u00f3n-Ponte","year":"2007","unstructured":"Le\u00f3n-Ponte M, Ahern GP, O\u2019Connell PJ. Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor. Blood. 2007;109(8):3139\u201346.","journal-title":"Blood"},{"issue":"1","key":"1748_CR209","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0165-5728(99)00101-0","volume":"99","author":"NA Khan","year":"1999","unstructured":"Khan NA, Poisson JP. 5-HT3 receptor-channels coupled with Na\u2009+\u2009influx in human T cells: role in T cell activation. J Neuroimmunol. 1999;99(1):53\u201360.","journal-title":"J Neuroimmunol"},{"issue":"9","key":"1748_CR210","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.4049\/jimmunol.142.9.3171","volume":"142","author":"JC Ameisen","year":"1989","unstructured":"Ameisen JC, Meade R, Askenase PW. A new interpretation of the involvement of serotonin in delayed-type hypersensitivity. Serotonin-2 receptor antagonists inhibit contact sensitivity by an effect on T cells. J Immunol (Baltimore Md: 1950). 1989;142(9):3171\u20139.","journal-title":"J Immunol (Baltimore Md: 1950)"},{"issue":"15","key":"1748_CR211","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.7150\/jca.20850","volume":"8","author":"X Zhang","year":"2017","unstructured":"Zhang X, Liu Q, Liao Q, Zhao Y. Potential roles of peripheral dopamine in tumor immunity. J Cancer. 2017;8(15):2966\u201373.","journal-title":"J Cancer"},{"issue":"11","key":"1748_CR212","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1210\/jcem.82.11.4339","volume":"82","author":"G Eisenhofer","year":"1997","unstructured":"Eisenhofer G, Aneman A, Friberg P, Hooper D, F\u00e5ndriks L, Lonroth H, et al. Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol Metab. 1997;82(11):3864\u201371.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1748_CR213","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/nm.4133","volume":"22","author":"TL Ben-Shaanan","year":"2016","unstructured":"Ben-Shaanan TL, Azulay-Debby H, Dubovik T, Starosvetsky E, Korin B, Schiller M, Green NL, Admon Y, Hakim F, Shen-Orr SS, et al. Activation of the reward system boosts innate and adaptive immunity. Nat Med. 2016;22(8):940\u20134.","journal-title":"Nat Med"},{"issue":"2","key":"1748_CR214","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/(SICI)1096-8628(19990416)88:2<116::AID-AJMG3>3.0.CO;2-Y","volume":"88","author":"H Kojima","year":"1999","unstructured":"Kojima H, Ohmori O, Shinkai T, Terao T, Suzuki T, Abe K. Dopamine D1 receptor gene polymorphism and schizophrenia in Japan. Am J Med Genet. 1999;88(2):116\u20139.","journal-title":"Am J Med Genet"},{"issue":"8","key":"1748_CR215","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.psyneuen.2003.09.007","volume":"29","author":"MA Teunis","year":"2004","unstructured":"Teunis MA, Heijnen CJ, Cools AR, Kavelaars A. Reduced splenic natural killer cell activity in rats with a hyperreactive dopaminergic system. Psychoneuroendocrinology. 2004;29(8):1058\u201364.","journal-title":"Psychoneuroendocrinology"},{"issue":"12","key":"1748_CR216","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/mnfr.201100229","volume":"55","author":"HA Al-Wadei","year":"2011","unstructured":"Al-Wadei HA, Ullah MF, Al-Wadei M. GABA (\u03b3-aminobutyric acid), a non-protein amino acid counters the \u03b2-adrenergic cascade-activated oncogenic signaling in pancreatic cancer: a review of experimental evidence. Mol Nutr Food Res. 2011;55(12):1745\u201358.","journal-title":"Mol Nutr Food Res"},{"issue":"7885","key":"1748_CR217","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41586-021-04082-1","volume":"599","author":"B Zhang","year":"2021","unstructured":"Zhang B, Vogelzang A, Miyajima M, Sugiura Y, Wu Y, Chamoto K, et al. B cell-derived GABA elicits IL-10(+) macrophages to limit anti-tumour immunity. Nature. 2021;599(7885):471\u20136.","journal-title":"Nature"},{"issue":"11","key":"1748_CR218","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1136\/gutjnl-2018-317479","volume":"68","author":"SH Jiang","year":"2019","unstructured":"Jiang SH, Zhu LL, Zhang M, Li RK, Yang Q, Yan JY, et al. GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca(2+) signalling in a GABA-independent manner. Gut. 2019;68(11):1994\u20132006.","journal-title":"Gut"},{"issue":"15","key":"1748_CR219","doi-asserted-by":"publisher","first-page":"5667","DOI":"10.1007\/s00018-021-03881-z","volume":"78","author":"AK Bhandage","year":"2021","unstructured":"Bhandage AK, Barragan A. GABAergic signaling by cells of the immune system: more the rule than the exception. Cell Mol Life Sci. 2021;78(15):5667\u201379.","journal-title":"Cell Mol Life Sci"},{"key":"1748_CR220","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ebiom.2018.03.019","volume":"30","author":"AK Bhandage","year":"2018","unstructured":"Bhandage AK, Jin Z, Korol SV, Shen Q, Pei Y, Deng Q, Espes D, Carlsson PO, Kamali-Moghaddam M, Birnir B. GABA regulates release of inflammatory cytokines from peripheral blood mononuclear cells and CD4(+) T cells and is immunosuppressive in type 1 diabetes. EBioMedicine. 2018;30:283\u201394.","journal-title":"EBioMedicine"},{"issue":"1","key":"1748_CR221","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1038\/s41467-018-06487-5","volume":"9","author":"JK Kim","year":"2018","unstructured":"Kim JK, Kim YS, Lee HM, Jin HS, Neupane C, Kim S, Lee SH, Min JJ, Sasai M, Jeong JH, et al. GABAergic signaling linked to autophagy enhances host protection against intracellular bacterial infections. Nat Commun. 2018;9(1):4184.","journal-title":"Nat Commun"},{"issue":"5","key":"1748_CR222","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","volume":"31","author":"S Spranger","year":"2017","unstructured":"Spranger S, Dai D, Horton B, Gajewski TF. Tumor-Residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy. Cancer Cell. 2017;31(5):711\u2013e723714.","journal-title":"Cancer Cell"},{"key":"1748_CR223","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.brainresbull.2019.04.018","volume":"149","author":"F Liu","year":"2019","unstructured":"Liu F, Zhang YY, Song N, Lin J, Liu MK, Huang CL, Zhou C, Wang H, Wang M, Shen JF. GABA(B) receptor activation attenuates inflammatory orofacial pain by modulating interleukin-1\u03b2 in satellite glial cells: role of NF-\u03baB and MAPK signaling pathways. Brain Res Bull. 2019;149:240\u201350.","journal-title":"Brain Res Bull"},{"issue":"7","key":"1748_CR224","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.1600-0625.2010.01076.x","volume":"19","author":"B Duthey","year":"2010","unstructured":"Duthey B, H\u00fcbner A, Diehl S, Boehncke S, Pfeffer J, Boehncke WH. Anti-inflammatory effects of the GABA(B) receptor agonist baclofen in allergic contact dermatitis. Exp Dermatol. 2010;19(7):661\u20136.","journal-title":"Exp Dermatol"},{"issue":"6","key":"1748_CR225","doi-asserted-by":"publisher","first-page":"966","DOI":"10.3390\/v13060966","volume":"13","author":"J Tian","year":"2021","unstructured":"Tian J, Middleton B, Kaufman DL. GABA(A)-receptor agonists limit pneumonitis and death in murine Coronavirus-infected mice. Viruses. 2021;13(6):966. https:\/\/doi.org\/10.3390\/v13060966.","journal-title":"Viruses"},{"issue":"1","key":"1748_CR226","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/biomedicines9010043","volume":"9","author":"J Tian","year":"2021","unstructured":"Tian J, Middleton B, Lee VS, Park HW, Zhang Z, Kim B, et al. GABA(B)-receptor agonist-based immunotherapy for type 1 diabetes in NOD mice. Biomedicines. 2021;9(1):43. https:\/\/doi.org\/10.3390\/biomedicines9010043.","journal-title":"Biomedicines"},{"issue":"3","key":"1748_CR227","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrm.2016.152","volume":"18","author":"ER Weikum","year":"2017","unstructured":"Weikum ER, Knuesel MT, Ortlund EA, Yamamoto KR. Glucocorticoid receptor control of transcription: precision and plasticity via allostery. Nat Rev Mol Cell Biol. 2017;18(3):159\u201374.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7843","key":"1748_CR228","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41586-020-03083-w","volume":"589","author":"YQ Ping","year":"2021","unstructured":"Ping YQ, Mao C, Xiao P, Zhao RJ, Jiang Y, Yang Z, et al. Structures of the glucocorticoid-bound adhesion receptor GPR97-G(o) complex. Nature. 2021;589(7843):620\u20136.","journal-title":"Nature"},{"issue":"3","key":"1748_CR229","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1189\/jlb.69.3.426","volume":"69","author":"KD Kim","year":"2001","unstructured":"Kim KD, Choe YK, Choe IS, Lim JS. Inhibition of glucocorticoid-mediated, caspase-independent dendritic cell death by CD40 activation. J Leukoc Biol. 2001;69(3):426\u201334.","journal-title":"J Leukoc Biol"},{"issue":"11","key":"1748_CR230","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1093\/intimm\/dxp093","volume":"21","author":"G Talab\u00e9r","year":"2009","unstructured":"Talab\u00e9r G, Boldizs\u00e1r F, Bartis D, P\u00e1link\u00e1s L, Szab\u00f3 M, Berta G, et al. Mitochondrial translocation of the glucocorticoid receptor in double-positive thymocytes correlates with their sensitivity to glucocorticoid-induced apoptosis. Int Immunol. 2009;21(11):1269\u201376.","journal-title":"Int Immunol"},{"issue":"6149","key":"1748_CR231","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/330658a0","volume":"330","author":"D Lindholm","year":"1987","unstructured":"Lindholm D, Heumann R, Meyer M, Thoenen H. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature. 1987;330(6149):658\u20139.","journal-title":"Nature"},{"issue":"5","key":"1748_CR232","doi-asserted-by":"publisher","first-page":"dmm037887","DOI":"10.1242\/dmm.037887","volume":"12","author":"Y Xie","year":"2019","unstructured":"Xie Y, Tolmeijer S, Oskam JM, Tonkens T, Meijer AH, Schaaf MJM. Glucocorticoids inhibit macrophage differentiation towards a pro-inflammatory phenotype upon wounding without affecting their migration. Dis Model Mech. 2019;12(5):dmm037887. https:\/\/doi.org\/10.1242\/dmm.037887.","journal-title":"Dis Model Mech"},{"issue":"9","key":"1748_CR233","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41590-018-0185-0","volume":"19","author":"L Quatrini","year":"2018","unstructured":"Quatrini L, Wieduwild E, Escaliere B, Filtjens J, Chasson L, Laprie C, Vivier E, Ugolini S. Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 expression on NK cells. Nat Immunol. 2018;19(9):954\u201362.","journal-title":"Nat Immunol"},{"issue":"6","key":"1748_CR234","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S1470-2045(18)30261-4","volume":"19","author":"F Conforti","year":"2018","unstructured":"Conforti F, Pala L, Bagnardi V, De Pas T, Martinetti M, Viale G, et al. Cancer immunotherapy efficacy and patients\u2019 sex: a systematic review and meta-analysis. Lancet Oncol. 2018;19(6):737\u201346.","journal-title":"Lancet Oncol"},{"issue":"3","key":"1748_CR235","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.2021.01.002","volume":"184","author":"K Litchfield","year":"2021","unstructured":"Litchfield K, Reading JL, Puttick C, Thakkar K, Abbosh C, Bentham R, Watkins TBK, Rosenthal R, Biswas D, Rowan A, et al. Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint Inhibition. Cell. 2021;184(3):596\u2013e614514.","journal-title":"Cell"},{"issue":"8","key":"1748_CR236","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/jnci\/djz094","volume":"111","author":"F Conforti","year":"2019","unstructured":"Conforti F, Pala L, Bagnardi V, Viale G, De Pas T, Pagan E, et al. Sex-based heterogeneity in response to lung cancer immunotherapy: a systematic review and meta-analysis. J Natl Cancer Inst. 2019;111(8):772\u201381.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"1748_CR237","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ccell.2022.06.005","volume":"40","author":"L Pala","year":"2022","unstructured":"Pala L, De Pas T, Catania C, Giaccone G, Mantovani A, Minucci S, et al. Sex and cancer immunotherapy: current understanding and challenges. Cancer Cell. 2022;40(7):695\u2013700.","journal-title":"Cancer Cell"},{"issue":"25","key":"1748_CR238","doi-asserted-by":"publisher","first-page":"14565","DOI":"10.1073\/pnas.251140998","volume":"98","author":"M Mercader","year":"2001","unstructured":"Mercader M, Bodner BK, Moser MT, Kwon PS, Park ES, Manecke RG, et al. T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer. Proc Natl Acad Sci U S A. 2001;98(25):14565\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"1748_CR239","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1158\/2326-6066.CIR-16-0390","volume":"5","author":"BM Olson","year":"2017","unstructured":"Olson BM, Gamat M, Seliski J, Sawicki T, Jeffery J, Ellis L, Drake CG, Weichert J. McNeel dgjcir: prostate cancer cells express more androgen receptor (AR) following androgen deprivation, improving recognition by AR-specific T cells. Cancer Immunol Res. 2017;5(12):1074\u201385.","journal-title":"Cancer Immunol Res."},{"issue":"11","key":"1748_CR240","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.ccell.2023.10.006","volume":"41","author":"JE Hawley","year":"2023","unstructured":"Hawley JE, Obradovic AZ, Dallos MC, Lim EA, Runcie K, Ager CR, McKiernan J, Anderson CB, Decastro GJ, Weintraub J, et al. Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer. Cancer Cell. 2023;41(11):1972\u201388. e1975.","journal-title":"Cancer Cell"},{"issue":"8","key":"1748_CR241","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1158\/2159-8290.CD-19-1355","volume":"10","author":"D Bayik","year":"2020","unstructured":"Bayik D, Zhou Y, Park C, Hong C, Vail D, Silver DJ, et al. Myeloid-derived suppressor cell subsets drive glioblastoma growth in a sex-specific manner. Cancer Discov. 2020;10(8):1210\u201325.","journal-title":"Cancer Discov"},{"key":"1748_CR242","doi-asserted-by":"crossref","unstructured":"Pathak A, Palasalava S, Knott MV, Colon B, Ciervo E, Zhou Y, Mitchell J, Pumar OT, Wong HK. Zhang ljb: \u03b3-aminobutyric acid receptor B signaling drives glioblastoma in females in an immune-dependent manner. bioRxiv. 2024;2024.07.18.603996.","DOI":"10.1101\/2024.07.18.603996"},{"issue":"1","key":"1748_CR243","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1158\/1078-0432.CCR-21-1193","volume":"28","author":"JC Lee","year":"2022","unstructured":"Lee JC, Green MD, Huppert LA, Chow C, Pierce RH, Daud AI. The liver-immunity nexus and cancer immunotherapy. Clin Cancer Res. 2022;28(1):5\u201312.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1748_CR244","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","volume":"27","author":"J Yu","year":"2021","unstructured":"Yu J, Green MD, Li S, Sun Y, Journey SN, Choi JE, Rizvi SM, Qin A, Waninger JJ, Lang X, et al. Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination. Nat Med. 2021;27(1):152\u201364.","journal-title":"Nat Med"},{"issue":"1","key":"1748_CR245","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.1038\/s41467-019-13571-x","volume":"10","author":"S Milette","year":"2019","unstructured":"Milette S, Hashimoto M, Perrino S, Qi S, Chen M, Ham B, et al. Sexual dimorphism and the role of estrogen in the immune microenvironment of liver metastases. Nat Commun. 2019;10(1):5745.","journal-title":"Nat Commun"},{"issue":"7","key":"1748_CR246","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/qjmed\/hcy154","volume":"112","author":"Y Huang","year":"2019","unstructured":"Huang Y, Zhao C, Su X. Neuroimmune regulation of lung infection and inflammation. QJM: Monthly J Association Physicians. 2019;112(7):483\u20137.","journal-title":"QJM: Monthly J Association Physicians"},{"issue":"5","key":"1748_CR247","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.cell.2015.07.021","volume":"162","author":"AL Cattin","year":"2015","unstructured":"Cattin AL, Burden JJ, Van Emmenis L, Mackenzie FE, Hoving JJ, Garcia Calavia N, Guo Y, McLaughlin M, Rosenberg LH, Quereda V, et al. Macrophage-Induced blood vessels guide Schwann Cell-Mediated regeneration of peripheral nerves. Cell. 2015;162(5):1127\u201339.","journal-title":"Cell"},{"issue":"1","key":"1748_CR248","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/ALN.0b013e31821b1ac5","volume":"115","author":"PW Mantyh","year":"2011","unstructured":"Mantyh PW, Koltzenburg M, Mendell LM, Tive L, Shelton DL. Antagonism of nerve growth factor-TrkA signaling and the relief of pain. Anesthesiology. 2011;115(1):189\u2013204.","journal-title":"Anesthesiology"},{"key":"1748_CR249","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1155333","volume":"14","author":"Q Li","year":"2023","unstructured":"Li Q, Hu YZ, Gao S, Wang PF, Hu ZL, Dai RP. ProBDNF and its receptors in immune-mediated inflammatory diseases: novel insights into the regulation of metabolism and mitochondria. Front Immunol. 2023;14:1155333.","journal-title":"Front Immunol"},{"issue":"3","key":"1748_CR250","doi-asserted-by":"publisher","DOI":"10.1186\/ar3826","volume":"14","author":"JM Jimenez-Andrade","year":"2012","unstructured":"Jimenez-Andrade JM, Mantyh PW. Sensory and sympathetic nerve fibers undergo sprouting and neuroma formation in the painful arthritic joint of geriatric mice. Arthritis Res Ther. 2012;14(3):R101.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1748_CR251","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0012-1606(89)90322-9","volume":"133","author":"M Mallat","year":"1989","unstructured":"Mallat M, Houlgatte R, Brachet P, Prochiantz A. Lipopolysaccharide-stimulated rat brain macrophages release NGF in vitro. Dev Biol. 1989;133(1):309\u201311.","journal-title":"Dev Biol"},{"issue":"9","key":"1748_CR252","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1073\/pnas.91.9.3739","volume":"91","author":"A Leon","year":"1994","unstructured":"Leon A, Buriani A, Dal Toso R, Fabris M, Romanello S, Aloe L, Levi-Montalcini R. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci U S A. 1994;91(9):3739\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1748_CR253","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.pneurobio.2018.12.001","volume":"173","author":"RE Zigmond","year":"2019","unstructured":"Zigmond RE, Echevarria FD. Macrophage biology in the peripheral nervous system after injury. Prog Neurobiol. 2019;173:102\u201321.","journal-title":"Prog Neurobiol"},{"issue":"1","key":"1748_CR254","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ccell.2017.11.007","volume":"33","author":"BW Renz","year":"2018","unstructured":"Renz BW, Takahashi R, Tanaka T, Macchini M, Hayakawa Y, Dantes Z, Maurer HC, Chen X, Jiang Z, Westphalen CB, et al. \u03b22 Adrenergic-Neurotrophin feedforward loop promotes pancreatic cancer. Cancer Cell. 2018;33(1):75\u2013e9077.","journal-title":"Cancer Cell"},{"issue":"4","key":"1748_CR255","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41388-021-02108-6","volume":"41","author":"CC Jiang","year":"2022","unstructured":"Jiang CC, Marsland M, Wang Y, Dowdell A, Eden E, Gao F, et al. Tumor innervation is triggered by endoplasmic reticulum stress. Oncogene. 2022;41(4):586\u201399.","journal-title":"Oncogene"},{"key":"1748_CR256","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2103505118","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Li Y, Lv X, Zhao L, Wang X. VLM catecholaminergic neurons control tumor growth by regulating CD8(+) T cells. Proc Natl Acad Sci U S A. 2021. https:\/\/doi.org\/10.1073\/pnas.2103505118.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6610","key":"1748_CR257","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1126\/science.abj2674","volume":"377","author":"Y Xu","year":"2022","unstructured":"Xu Y, Yan J, Tao Y, Qian X, Zhang C, Yin L, Gu P, Liu Y, Pan Y, Tang R, et al. Pituitary hormone \u03b1-MSH promotes tumor-induced myelopoiesis and immunosuppression. Science. 2022;377(6610):1085\u201391.","journal-title":"Science"},{"issue":"9","key":"1748_CR258","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/onc.2016.306","volume":"36","author":"L Zhang","year":"2017","unstructured":"Zhang L, Wang P, Qin Y, Cong Q, Shao C, Du Z, Ni X, Li P, Ding K. RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 associated signaling pathways. Oncogene. 2017;36(9):1297\u2013308.","journal-title":"Oncogene"},{"issue":"4","key":"1748_CR259","doi-asserted-by":"publisher","first-page":"e002371","DOI":"10.1136\/jitc-2021-002371","volume":"9","author":"BD Curti","year":"2021","unstructured":"Curti BD, Koguchi Y, Leidner RS, Rolig AS, Sturgill ER, Sun Z, et al. Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor. J Immunother Cancer. 2021;9(4):e002371. https:\/\/doi.org\/10.1136\/jitc-2021-002371.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"1748_CR260","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-01928-2","volume":"4","author":"SA Hunter","year":"2021","unstructured":"Hunter SA, McIntosh BJ, Shi Y, Sperberg RAP, Funatogawa C, Labanieh L, et al. An engineered ligand trap inhibits leukemia inhibitory factor as pancreatic cancer treatment strategy. Commun Biol. 2021;4(1):452.","journal-title":"Commun Biol"},{"key":"1748_CR261","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/S0959-8049(16)32663-6","volume":"69","author":"H Nair","year":"2016","unstructured":"Nair H, Santhamma B, Viswanadhapalli S, Sareddy G, Manthati V, Vadlamudi R, et al. Discovery and preclinical pharmacology of EC330: a first-in-class leukemia inhibitory factor (LIF) inhibitor. Eur J Cancer. 2016;69:S28.","journal-title":"Eur J Cancer"},{"issue":"12","key":"1748_CR262","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1002\/ijc.32061","volume":"144","author":"RJ Mo","year":"2019","unstructured":"Mo RJ, Han ZD, Liang YK, Ye JH, Wu SL, Lin SX, et al. Expression of PD-L1 in tumor-associated nerves correlates with reduced CD8(+) tumor-associated lymphocytes and poor prognosis in prostate cancer. Int J Cancer. 2019;144(12):3099\u2013110.","journal-title":"Int J Cancer"},{"issue":"1","key":"1748_CR263","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-023-00459-2","volume":"12","author":"Q Huang","year":"2023","unstructured":"Huang Q, Wang F, Hao D, Li X, Li X, Lei T, et al. Deciphering tumor-infiltrating dendritic cells in the single-cell era. Exp Hematol Oncol. 2023;12(1):97.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"1748_CR264","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01885-w","volume":"22","author":"M Yi","year":"2023","unstructured":"Yi M, Li T, Niu M, Mei Q, Zhao B, Chu Q, et al. Exploiting innate immunity for cancer immunotherapy. Mol Cancer. 2023;22(1):187.","journal-title":"Mol Cancer"},{"issue":"1","key":"1748_CR265","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01489-2","volume":"21","author":"M Yi","year":"2022","unstructured":"Yi M, Zheng X, Niu M, Zhu S, Ge H, Wu K. Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions. Mol Cancer. 2022;21(1):28.","journal-title":"Mol Cancer"},{"issue":"1","key":"1748_CR266","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-023-00469-0","volume":"13","author":"M Cao","year":"2024","unstructured":"Cao M, Wang Z, Lan W, Xiang B, Liao W, Zhou J, et al. The roles of tissue resident macrophages in health and cancer. Exp Hematol Oncol. 2024;13(1):3.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"1748_CR267","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13045-024-01559-0","volume":"17","author":"B Toledo","year":"2024","unstructured":"Toledo B, Zhu Chen L, Paniagua-Sancho M, Marchal JA, Per\u00e1n M, Giovannetti E. Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy. J Hematol Oncol. 2024;17(1):44.","journal-title":"J Hematol Oncol"},{"issue":"20","key":"1748_CR268","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.1158\/0008-5472.CAN-17-0546","volume":"77","author":"MJ Bucsek","year":"2017","unstructured":"Bucsek MJ, Qiao G, MacDonald CR, Giridharan T, Evans L, Niedzwecki B, et al. \u03b2-adrenergic signaling in mice housed at standard temperatures suppresses an effector phenotype in CD8(+) T cells and undermines checkpoint inhibitor therapy. Cancer Res. 2017;77(20):5639\u201351.","journal-title":"Cancer Res"},{"issue":"3","key":"1748_CR269","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1405205","volume":"7","author":"KM Kokolus","year":"2018","unstructured":"Kokolus KM, Zhang Y, Sivik JM, Schmeck C, Zhu J, Repasky EA, et al. Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice. Oncoimmunology. 2018;7(3):e1405205.","journal-title":"Oncoimmunology"},{"issue":"1","key":"1748_CR270","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1158\/1078-0432.CCR-20-2381","volume":"27","author":"S Gandhi","year":"2021","unstructured":"Gandhi S, Pandey MR, Attwood K, Ji W, Witkiewicz AK, Knudsen ES, et al. Phase I clinical trial of combination propranolol and pembrolizumab in locally advanced and metastatic melanoma: safety, tolerability, and preliminary evidence of antitumor activity. Clin Cancer Res. 2021;27(1):87\u201395.","journal-title":"Clin Cancer Res"},{"key":"1748_CR271","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ejca.2022.01.017","volume":"165","author":"OJ Kennedy","year":"2022","unstructured":"Kennedy OJ, Kicinski M, Valpione S, Gandini S, Suciu S, Blank CU, et al. Prognostic and predictive value of \u03b2-blockers in the EORTC 1325\/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma. Eur J Cancer. 2022;165:97\u2013112.","journal-title":"Eur J Cancer"},{"issue":"1","key":"1748_CR272","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/s41467-020-15676-0","volume":"11","author":"M Chen","year":"2020","unstructured":"Chen M, Qiao G, Hylander BL, Mohammadpour H, Wang XY, Subjeck JR, Singh AK, Repasky EA. Adrenergic stress constrains the development of anti-tumor immunity and abscopal responses following local radiation. Nat Commun. 2020;11(1):1821.","journal-title":"Nat Commun"},{"issue":"17","key":"1748_CR273","doi-asserted-by":"publisher","first-page":"E4041","DOI":"10.1073\/pnas.1720948115","volume":"115","author":"E Peranzoni","year":"2018","unstructured":"Peranzoni E, Lemoine J, Vimeux L, Feuillet V, Barrin S, Kantari-Mimoun C, et al. Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment. Proc Natl Acad Sci U S A. 2018;115(17):E4041-50.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1748_CR274","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11280-z","volume":"10","author":"M Leclerc","year":"2019","unstructured":"Leclerc M, Voilin E, Gros G, Corgnac S, de Montpr\u00e9ville V, Validire P, et al. Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1. Nat Commun. 2019;10(1):3345.","journal-title":"Nat Commun"},{"key":"1748_CR275","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.6789.1","volume":"4","author":"T Koltai","year":"2015","unstructured":"Koltai T. Voltage-gated sodium channel as a target for metastatic risk reduction with re-purposed drugs. F1000Res. 2015;4:297.","journal-title":"F1000Res"},{"issue":"11","key":"1748_CR276","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.3390\/cancers11111675","volume":"11","author":"MBA Djamgoz","year":"2019","unstructured":"Djamgoz MBA, Fraser SP, Brackenbury WJ. In vivo evidence for voltage-gated sodium channel expression in carcinomas and potentiation of metastasis. Cancers (Basel). 2019;11(11):1675. https:\/\/doi.org\/10.3390\/cancers11111675.","journal-title":"Cancers (Basel)"},{"issue":"15","key":"1748_CR277","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.1093\/emboj\/16.15.4597","volume":"16","author":"W Tsai","year":"1997","unstructured":"Tsai W, Morielli AD, Peralta EG. The M1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity. EMBO J. 1997;16(15):4597\u2013605.","journal-title":"EMBO J"},{"key":"1748_CR278","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8445093","volume":"2022","author":"T Peng","year":"2022","unstructured":"Peng T, Guo Y, Gan Z, Ling Y, Xiong J, Liang X, et al. Nerve growth factor (NGF) encourages the neuroinvasive potential of pancreatic cancer cells by activating the Warburg effect and promoting tumor derived exosomal miRNA-21 expression. Oxid Med Cell Longev. 2022;2022:8445093.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"1748_CR279","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1756-9966-30-97","volume":"30","author":"D Guo","year":"2011","unstructured":"Guo D, Hou X, Zhang H, Sun W, Zhu L, Liang J, Jiang X. More expressions of BDNF and TrkB in multiple hepatocellular carcinoma and anti-BDNF or K252a induced apoptosis, supressed invasion of HepG2 and HCCLM3 cells. J Exp Clin Cancer Res. 2011;30(1):97.","journal-title":"J Exp Clin Cancer Res"},{"key":"1748_CR280","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4598573","volume":"2022","author":"S Guangshun","year":"2022","unstructured":"Guangshun S, Guoqiang S, Xin C, Xiangyi K, Wubin Z, Zhitao L, et al. Meloxicam inhibits hepatocellular carcinoma progression and enhances the sensitivity of immunotherapy via the microRNA-200\/PD-L1 pathway. J Oncol. 2022;2022:4598573.","journal-title":"J Oncol"},{"issue":"7973","key":"1748_CR281","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-023-06372-2","volume":"620","author":"J Lengrand","year":"2023","unstructured":"Lengrand J, Pastushenko I, Vanuytven S, Song Y, Venet D, Sarate RM, Bellina M, Moers V, Boinet A, Sifrim A, et al. Pharmacological targeting of netrin-1 inhibits EMT in cancer. Nature. 2023;620(7973):402\u20138.","journal-title":"Nature"},{"issue":"7973","key":"1748_CR282","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41586-023-06367-z","volume":"620","author":"PA Cassier","year":"2023","unstructured":"Cassier PA, Navaridas R, Bellina M, Rama N, Ducarouge B, Hernandez-Vargas H, et al. Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer. Nature. 2023;620(7973):409\u201316.","journal-title":"Nature"},{"issue":"2","key":"1748_CR283","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.neuroscience.2009.01.022","volume":"159","author":"T Nishimura","year":"2009","unstructured":"Nishimura T, Kubosaki A, Ito Y, Notkins AL. Disturbances in the secretion of neurotransmitters in IA-2\/IA-2beta null mice: changes in behavior, learning and lifespan. Neuroscience. 2009;159(2):427\u201337.","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"1748_CR284","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.mce.2009.09.023","volume":"315","author":"T Nishimura","year":"2010","unstructured":"Nishimura T, Harashima S, Yafang H, Notkins AL. Ia-2 modulates dopamine secretion in PC12 cells. Mol Cell Endocrinol. 2010;315(1\u20132):81\u20136.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"1748_CR285","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12967-016-1036-0","volume":"14","author":"H Xu","year":"2016","unstructured":"Xu H, Cai T, Carmona GN, Abuhatzira L, Notkins AL. Small cell lung cancer growth is inhibited by miR-342 through its effect of the target gene IA-2. J Transl Med. 2016;14(1):278.","journal-title":"J Transl Med"},{"issue":"7","key":"1748_CR286","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1158\/1078-0432.CCR-15-1275","volume":"22","author":"Y Kang","year":"2016","unstructured":"Kang Y, Nagaraja AS, Armaiz-Pena GN, Dorniak PL, Hu W, Rupaimoole R, et al. Adrenergic stimulation of DUSP1 impairs chemotherapy response in ovarian cancer. Clin Cancer Res. 2016;22(7):1713\u201324.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"1748_CR287","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1158\/0008-5472.CAN-19-2689","volume":"80","author":"MW Yang","year":"2020","unstructured":"Yang MW, Tao LY, Jiang YS, Yang JY, Huo YM, Liu DJ, et al. Perineural invasion reprograms the immune microenvironment through cholinergic signaling in pancreatic ductal adenocarcinoma. Cancer Res. 2020;80(10):1991\u20132003.","journal-title":"Cancer Res"},{"issue":"1","key":"1748_CR288","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-015-0159-0","volume":"34","author":"V Liu","year":"2015","unstructured":"Liu V, Dietrich A, Kasparek MS, Benhaqi P, Schneider MR, Schemann M, et al. Extrinsic intestinal denervation modulates tumor development in the small intestine of Apc(Min\/+) mice. J Exp Clin Cancer Res. 2015;34(1):39.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1748_CR289","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0304-3835(02)00584-0","volume":"190","author":"AC Polli-Lopes","year":"2003","unstructured":"Polli-Lopes AC, Zucoloto S, de Queir\u00f3s Cunha F, da Silva Figueiredo LA, Garcia SB. Myenteric denervation reduces the incidence of gastric tumors in rats. Cancer Lett. 2003;190(1):45\u201350.","journal-title":"Cancer Lett"},{"issue":"6","key":"1748_CR290","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/08820139.2023.2232403","volume":"52","author":"S Kwak","year":"2023","unstructured":"Kwak S, Lee JY, Kim MJ, Lee HJ, Lee DK, Kang J, et al. Combination of PD-1 checkpoint blockade and botulinum toxin type A1 improves antitumor responses in mouse tumor models of melanoma and colon carcinoma. Immunol Invest. 2023;52(6):749\u201366.","journal-title":"Immunol Invest"},{"issue":"2","key":"1748_CR291","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.neuchi.2020.10.003","volume":"67","author":"SM Farrell","year":"2021","unstructured":"Farrell SM, Pereira EAC, Brown MRD, Green AL, Aziz TZ. Neuroablative surgical treatments for pain due to cancer. Neurochirurgie. 2021;67(2):176\u201388.","journal-title":"Neurochirurgie"},{"issue":"7003","key":"1748_CR292","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/nature02765","volume":"430","author":"S Douma","year":"2004","unstructured":"Douma S, Van Laar T, Zevenhoven J, Meuwissen R, Van Garderen E, Peeper DS. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature. 2004;430(7003):1034\u20139.","journal-title":"Nature"},{"key":"1748_CR293","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2407-10-43","volume":"10","author":"S Zhang","year":"2010","unstructured":"Zhang S, Guo D, Luo W, Zhang Q, Zhang Y, Li C, Lu Y, Cui Z, Qiu X. TrkB is highly expressed in NSCLC and mediates BDNF-induced the activation of Pyk2 signaling and the invasion of A549 cells. BMC Cancer. 2010;10:43.","journal-title":"BMC Cancer"},{"issue":"4","key":"1748_CR294","first-page":"943","volume":"37","author":"YT Huang","year":"2010","unstructured":"Huang YT, Lai PC, Wu CC, Cheng CC, Chiu TH. Trkb antibody elicits cytotoxicity and suppresses migration\/invasion of transitional cell carcinoma cells. Int J Oncol. 2010;37(4):943\u20139.","journal-title":"Int J Oncol"},{"issue":"6","key":"1748_CR295","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/cam4.158","volume":"2","author":"K Kawamura","year":"2013","unstructured":"Kawamura K, Kawamura N, Okamoto N, Manabe M. Suppression of choriocarcinoma invasion and metastasis following blockade of BDNF\/TrkB signaling. Cancer Med. 2013;2(6):849\u201361.","journal-title":"Cancer Med"},{"issue":"4","key":"1748_CR296","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/1061186X.2018.1533964","volume":"27","author":"J Zou","year":"2019","unstructured":"Zou J, Zhang Z, Xu F, Cui S, Qi C, Luo J, et al. GZD2202, a novel TrkB inhibitor, suppresses BDNF-mediated proliferation and metastasis in neuroblastoma models. J Drug Target. 2019;27(4):442\u201350.","journal-title":"J Drug Target"},{"issue":"11\u201312","key":"1748_CR297","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s10495-024-01936-7","volume":"29","author":"D Liang","year":"2024","unstructured":"Liang D, Tang J, Sun B, He S, Yang D, Ma H, et al. Novel CAR-T cells targeting TRKB for the treatment of solid cancer. Apoptosis. 2024;29(11\u201312):2183\u201396.","journal-title":"Apoptosis"},{"key":"1748_CR298","doi-asserted-by":"publisher","first-page":"1070961","DOI":"10.3389\/fimmu.2022.1070961","volume":"13","author":"Q Li","year":"2022","unstructured":"Li Q, Han J, Yang Y, Chen Y. PD-1\/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy. Front Immunol. 2022;13:1070961.","journal-title":"Front Immunol"},{"issue":"7","key":"1748_CR299","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.tibtech.2021.12.009","volume":"40","author":"ER Vander Mause","year":"2022","unstructured":"Vander Mause ER, Atanackovic D, Lim CS, Luetkens T. Roadmap to affinity-tuned antibodies for enhanced chimeric antigen receptor T cell function and selectivity. Trends Biotechnol. 2022;40(7):875\u201390.","journal-title":"Trends Biotechnol"},{"issue":"5178","key":"1748_CR300","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1126\/science.8079174","volume":"265","author":"RT Dobrowsky","year":"1994","unstructured":"Dobrowsky RT, Werner MH, Castellino AM, Chao MV, Hannun YA. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science. 1994;265(5178):1596\u20139.","journal-title":"Science"},{"issue":"4","key":"1748_CR301","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/j.1476-5381.2010.01094.x","volume":"162","author":"M Cazorla","year":"2011","unstructured":"Cazorla M, Arrang JM, Pr\u00e9mont J. Pharmacological characterization of six TrkB antibodies reveals a novel class of functional agents for the study of the BDNF receptor. Br J Pharmacol. 2011;162(4):947\u201360.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1748_CR302","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12943-019-1057-4","volume":"18","author":"S Yu","year":"2019","unstructured":"Yu S, Yi M, Qin S, Wu K. Next generation chimeric antigen receptor T cells: safety strategies to overcome toxicity. Mol Cancer. 2019;18(1):125.","journal-title":"Mol Cancer"},{"issue":"12","key":"1748_CR303","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1158\/1078-0432.CCR-16-1518","volume":"23","author":"J Portnow","year":"2017","unstructured":"Portnow J, Synold TW, Badie B, Tirughana R, Lacey SF, D\u2019Apuzzo M, Metz MZ, Najbauer J, Bedell V, Vo T, et al. Neural stem Cell-Based anticancer gene therapy: A First-in-Human study in recurrent High-Grade glioma patients. Clin Cancer Res. 2017;23(12):2951\u201360.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1748_CR304","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/cgt.2012.21","volume":"19","author":"B Thaci","year":"2012","unstructured":"Thaci B, Ahmed AU, Ulasov IV, Tobias AL, Han Y, Aboody KS, Lesniak MS. Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model. Cancer Gene Ther. 2012;19(6):431\u201342.","journal-title":"Cancer Gene Ther"},{"issue":"9","key":"1748_CR305","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/mt.2011.100","volume":"19","author":"AU Ahmed","year":"2011","unstructured":"Ahmed AU, Thaci B, Alexiades NG, Han Y, Qian S, Liu F, Balyasnikova IV, Ulasov IY, Aboody KS, Lesniak MS. Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma. Mol Ther. 2011;19(9):1714\u201326.","journal-title":"Mol Ther"},{"issue":"1","key":"1748_CR306","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/cgt.2014.72","volume":"22","author":"RA Morshed","year":"2015","unstructured":"Morshed RA, Gutova M, Juliano J, Barish ME, Hawkins-Daarud A, Oganesyan D, Vazgen K, Yang T, Annala A, Ahmed AU, et al. Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction. Cancer Gene Ther. 2015;22(1):55\u201361.","journal-title":"Cancer Gene Ther"},{"issue":"8","key":"1748_CR307","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S1470-2045(21)00245-X","volume":"22","author":"J Fares","year":"2021","unstructured":"Fares J, Ahmed AU, Ulasov IV, Sonabend AM, Miska J, Lee-Chang C, et al. Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial. Lancet Oncol. 2021;22(8):1103\u201314.","journal-title":"Lancet Oncol"},{"key":"1748_CR308","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.omto.2018.12.003","volume":"12","author":"R Mooney","year":"2019","unstructured":"Mooney R, Majid AA, Batalla-Covello J, Machado D, Liu X, Gonzaga J, et al. Enhanced delivery of oncolytic adenovirus by neural stem cells for treatment of metastatic ovarian cancer. Mol Ther Oncolytics. 2019;12:79\u201392.","journal-title":"Mol Ther Oncolytics"},{"issue":"10","key":"1748_CR309","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1523\/JNEUROSCI.5118-04.2005","volume":"25","author":"R Glass","year":"2005","unstructured":"Glass R, Synowitz M, Kronenberg G, Walzlein JH, Markovic DS, Wang LP, Gast D, Kiwit J, Kempermann G, Kettenmann H. Glioblastoma-induced attraction of endogenous neural precursor cells is associated with improved survival. J Neuroscience: Official J Soc Neurosci. 2005;25(10):2637\u201346.","journal-title":"J Neuroscience: Official J Soc Neurosci"},{"issue":"23","key":"1748_CR310","doi-asserted-by":"publisher","first-page":"12846","DOI":"10.1073\/pnas.97.23.12846","volume":"97","author":"KS Aboody","year":"2000","unstructured":"Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci U S A. 2000;97(23):12846\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1748_CR311","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000023","volume":"1","author":"KS Aboody","year":"2006","unstructured":"Aboody KS, Bush RA, Garcia E, Metz MZ, Najbauer J, Justus KA, et al. Development of a tumor-selective approach to treat metastatic cancer. PLoS ONE. 2006;1(1):e23.","journal-title":"PLoS ONE"},{"issue":"1","key":"1748_CR312","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1158\/0008-5472.CAN-06-3607","volume":"67","author":"MK Danks","year":"2007","unstructured":"Danks MK, Yoon KJ, Bush RA, Remack JS, Wierdl M, Tsurkan L, et al. Tumor-targeted enzyme\/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma. Cancer Res. 2007;67(1):22\u20135.","journal-title":"Cancer Res"},{"issue":"12","key":"1748_CR313","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008314","volume":"4","author":"RT Frank","year":"2009","unstructured":"Frank RT, Edmiston M, Kendall SE, Najbauer J, Cheung CW, Kassa T, et al. Neural stem cells as a novel platform for tumor-specific delivery of therapeutic antibodies. PLoS ONE. 2009;4(12):e8314.","journal-title":"PLoS ONE"},{"issue":"6","key":"1748_CR314","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1021\/acs.bioconjchem.7b00237","volume":"28","author":"P Cao","year":"2017","unstructured":"Cao P, Mooney R, Tirughana R, Abidi W, Aramburo S, Flores L, et al. Intraperitoneal administration of neural stem cell-nanoparticle conjugates targets chemotherapy to ovarian tumors. Bioconjug Chem. 2017;28(6):1767\u201376.","journal-title":"Bioconjug Chem"},{"key":"1748_CR315","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3389\/fneur.2019.00824","volume":"10","author":"X Lan","year":"2019","unstructured":"Lan X, Sun Z, Chu C, Boltze J, Li S. Dental pulp stem cells: an attractive alternative for cell therapy in ischemic stroke. Front Neurol. 2019;10:824.","journal-title":"Front Neurol"},{"issue":"5","key":"1748_CR316","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/scd.2008.0253","volume":"18","author":"UM Fischer","year":"2009","unstructured":"Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 2009;18(5):683\u201392.","journal-title":"Stem Cells Dev"},{"issue":"10","key":"1748_CR317","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1200\/JCO.2013.51.8860","volume":"32","author":"JK Kiecolt-Glaser","year":"2014","unstructured":"Kiecolt-Glaser JK, Bennett JM, Andridge R, Peng J, Shapiro CL, Malarkey WB, Emery CF, Layman R, Mrozek EE, Glaser R. Yoga\u2019s impact on inflammation, mood, and fatigue in breast cancer survivors: a randomized controlled trial. J Clin Oncol. 2014;32(10):1040\u20139.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1748_CR318","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10549-015-3626-6","volume":"154","author":"JM Stagl","year":"2015","unstructured":"Stagl JM, Lechner SC, Carver CS, Bouchard LC, Gudenkauf LM, Jutagir DR, Diaz A, Yu Q, Blomberg BB, Ironson G, et al. A randomized controlled trial of cognitive-behavioral stress management in breast cancer: survival and recurrence at 11-year follow-up. Breast Cancer Res Treat. 2015;154(2):319\u201328.","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"1748_CR319","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/pon.5103","volume":"28","author":"I Teo","year":"2019","unstructured":"Teo I, Krishnan A, Lee GL. Psychosocial interventions for advanced cancer patients: a systematic review. Psycho-Oncol. 2019;28(7):1394\u2013407.","journal-title":"Psycho-Oncol"},{"issue":"1","key":"1748_CR320","doi-asserted-by":"publisher","first-page":"5725","DOI":"10.1038\/s41467-021-25967-9","volume":"12","author":"C Liu","year":"2021","unstructured":"Liu C, Yang Y, Chen C, Li L, Li J, Wang X, Chu Q, Qiu L, Ba Q, Li X, et al. Environmental eustress modulates \u03b2-ARs\/CCL2 axis to induce anti-tumor immunity and sensitize immunotherapy against liver cancer in mice. Nat Commun. 2021;12(1):5725.","journal-title":"Nat Commun"},{"issue":"1","key":"1748_CR321","doi-asserted-by":"publisher","first-page":"1677427","DOI":"10.1080\/2162402X.2019.1677427","volume":"9","author":"AS Hamy","year":"2020","unstructured":"Hamy AS, Derosa L, Valdeli\u00e8vre C, Yonekura S, Opolon P, Priour M, Guerin J, Pierga JY, Asselain B, De Croze D, et al. Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer. Oncoimmunology. 2020;9(1):1677427.","journal-title":"Oncoimmunology"},{"issue":"11","key":"1748_CR322","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1249\/01.mss.0000175857.84936.1a","volume":"37","author":"NA Hutnick","year":"2005","unstructured":"Hutnick NA, Williams NI, Kraemer WJ, Orsega-Smith E, Dixon RH, Bleznak AD, Mastro AM. Exercise and lymphocyte activation following chemotherapy for breast cancer. Med Sci Sports Exerc. 2005;37(11):1827\u201335.","journal-title":"Med Sci Sports Exerc"},{"issue":"5","key":"1748_CR323","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/bjc.2014.662","volume":"112","author":"OK Glass","year":"2015","unstructured":"Glass OK, Inman BA, Broadwater G, Courneya KS, Mackey JR, Goruk S, Nelson ER, Jasper J, Field CJ, Bain JR, et al. Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study. Br J Cancer. 2015;112(5):825\u201331.","journal-title":"Br J Cancer"},{"issue":"11","key":"1748_CR324","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1249\/MSS.0000000000002116","volume":"51","author":"KL Campbell","year":"2019","unstructured":"Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, et al. Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. 2019;51(11):2375\u201390.","journal-title":"Med Sci Sports Exerc"},{"issue":"2","key":"1748_CR325","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1249\/MSS.0000000000002154","volume":"52","author":"VANV JK","year":"2020","unstructured":"JK VANV, Sweegers MG, Peeters PHM, Courneya KS, Newton RU, Aaronson NK, Jacobsen PB, Galv\u00e3o DA, Chinapaw MJ, Steindorf K, et al. Moderators of exercise effects on Cancer-related fatigue: A Meta-analysis of individual patient data. Med Sci Sports Exerc. 2020;52(2):303\u201314.","journal-title":"Med Sci Sports Exerc"},{"key":"1748_CR326","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ctrv.2016.11.010","volume":"52","author":"LM Buffart","year":"2017","unstructured":"Buffart LM, Kalter J, Sweegers MG, Courneya KS, Newton RU, Aaronson NK, et al. Effects and moderators of exercise on quality of life and physical function in patients with cancer: an individual patient data meta-analysis of 34 RCTs. Cancer Treat Rev. 2017;52:91\u2013104.","journal-title":"Cancer Treat Rev"},{"key":"1748_CR327","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.imlet.2021.08.005","volume":"239","author":"LA Buss","year":"2021","unstructured":"Buss LA, Williams T, Hock B, Ang AD, Robinson BA, Currie MJ, Dachs GU. Effects of exercise and anti-PD-1 on the tumour microenvironment. Immunol Lett. 2021;239:60\u201371.","journal-title":"Immunol Lett"},{"issue":"7","key":"1748_CR328","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.ccell.2022.05.006","volume":"40","author":"E Kurz","year":"2022","unstructured":"Kurz E, Hirsch CA, Dalton T, Shadaloey SA, Khodadadi-Jamayran A, Miller G, Pareek S, Rajaei H, Mohindroo C, Baydogan S, et al. Exercise-induced engagement of the IL-15\/IL-15R\u03b1 axis promotes anti-tumor immunity in pancreatic cancer. Cancer Cell. 2022;40(7):720\u2013e737725.","journal-title":"Cancer Cell"},{"key":"1748_CR329","first-page":"100","volume":"26","author":"A Mart\u00edn-Ruiz","year":"2020","unstructured":"Mart\u00edn-Ruiz A, Fiuza-Luces C, Rinc\u00f3n-Castanedo C, Fern\u00e1ndez-Moreno D, G\u00e1lvez BG, Mart\u00ednez-Mart\u00ednez E, Mart\u00edn-Acosta P, Coronado MJ, Franco-Luz\u00f3n L, Gonz\u00e1lez-Murillo \u00c1, et al. Benefits of exercise and immunotherapy in a murine model of human non-small-cell lung carcinoma. Exerc Immunol Rev. 2020;26:100\u201315.","journal-title":"Exerc Immunol Rev"},{"issue":"12","key":"1748_CR330","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1080\/0284186X.2020.1817550","volume":"59","author":"ML Bay","year":"2020","unstructured":"Bay ML, Unterrainer N, Stagaard R, Pedersen KS, Schauer T, Staffeldt MM, Christensen JF, Hojman P, Pedersen BK, Gehl J. Voluntary wheel running can lead to modulation of immune checkpoint molecule expression. Acta Oncol (Stockholm Sweden). 2020;59(12):1447\u201354.","journal-title":"Acta Oncol (Stockholm Sweden)"},{"issue":"1","key":"1748_CR331","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41419-024-06462-7","volume":"15","author":"S Chen","year":"2024","unstructured":"Chen S, Zhang W, Li X, Cao Z, Liu C. DNA polymerase beta connects tumorigenicity with the circadian clock in liver cancer through the epigenetic demethylation of Per1. Cell Death Dis. 2024;15(1):78.","journal-title":"Cell Death Dis"},{"issue":"3","key":"1748_CR332","volume":"1878","author":"SM Ortega-Campos","year":"2023","unstructured":"Ortega-Campos SM, Verdugo-Sivianes EM, Amiama-Roig A, Blanco JR, Carnero A. Interactions of circadian clock genes with the hallmarks of cancer. Biochimica et Biophysica Acta (BBA). 2023;1878(3):188900.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"15_suppl","key":"1748_CR333","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.e21585","volume":"38","author":"A Karabou\u00e9","year":"2020","unstructured":"Karabou\u00e9 A, Bisseux L, Pavese I, Collon T. Circadian variation in nivolumab efficacy in patients with advanced non-small cell lung cancer. J Clin Oncol. 2020;38(15_suppl):e21585\u201321585.","journal-title":"J Clin Oncol"},{"issue":"7","key":"1748_CR334","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/s41590-024-01859-0","volume":"25","author":"BM Fortin","year":"2024","unstructured":"Fortin BM, Pfeiffer SM, Insua-Rodr\u00edguez J, Alshetaiwi H, Moshensky A, Song WA, et al. Circadian control of tumor immunosuppression affects efficacy of immune checkpoint blockade. Nat Immunol. 2024;25(7):1257\u201369.","journal-title":"Nat Immunol"},{"issue":"3","key":"1748_CR335","doi-asserted-by":"publisher","first-page":"e008011","DOI":"10.1136\/jitc-2023-008011","volume":"12","author":"JS Patel","year":"2024","unstructured":"Patel JS, Woo Y, Draper A, Jansen CS, Carlisle JW, Innominato PF, et al. Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis. J Immunother Cancer. 2024;12(3):e008011. https:\/\/doi.org\/10.1136\/jitc-2023-008011.","journal-title":"J Immunother Cancer"},{"issue":"12","key":"1748_CR336","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/S1470-2045(21)00546-5","volume":"22","author":"DC Qian","year":"2021","unstructured":"Qian DC, Kleber T, Brammer B, Xu KM, Switchenko JM, Janopaul-Naylor JR, et al. Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study. Lancet Oncol. 2021;22(12):1777\u201386.","journal-title":"Lancet Oncol"},{"issue":"3","key":"1748_CR337","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.trecan.2023.11.002","volume":"10","author":"X Zhu","year":"2024","unstructured":"Zhu X, Maier G, Panda S. Learning from circadian rhythm to transform cancer prevention, prognosis, and survivorship care. Trends Cancer. 2024;10(3):196\u2013207.","journal-title":"Trends Cancer"},{"issue":"14","key":"1748_CR338","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1158\/0008-5472.CAN-17-3973","volume":"78","author":"X Hu","year":"2018","unstructured":"Hu X, Majchrzak K, Liu X, Wyatt MM, Spooner CJ, Moisan J, Zou W, Carter LL, Paulos CM. In vitro priming of adoptively transferred T cells with a ROR\u03b3 agonist confers durable memory and stemness in vivo. Cancer Res. 2018;78(14):3888\u201398.","journal-title":"Cancer Res"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-025-01748-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-025-01748-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-025-01748-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:09:46Z","timestamp":1761656986000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-025-01748-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":338,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1748"],"URL":"https:\/\/doi.org\/10.1186\/s13045-025-01748-5","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"21 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}